RxNorm Semantic Concepts Index - 194
What is RxNorm?
RxNorm is a system developed and maintained by the National Library of Medicine (NLM). RxNorm is a normalized naming system for generic and branded drugs. RxNorm is also a tool that supports interoperability between different drug terminologies and other naming systems.
The following table is a complete listing of RxNorm concepts whose unique RxCUI identifier starts with "194".
| RxCUI | Name | Term Type | Term Type Description | Is Prescribable? |
|---|---|---|---|---|
| RxCUI: 194 | Acetylcholine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 194 | Acetylcholine | Designated preferred name (PT) | YES | |
| RxCUI: 194 | Acetylcholine | Full form of descriptor (FN) | YES | |
| RxCUI: 194 | Acetylcholine | Designated preferred name (PT) | YES | |
| RxCUI: 194 | Acetylcholine | Full form of descriptor (FN) | YES | |
| RxCUI: 194000 | capecitabine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 194000 | capecitabine | Designated preferred name (PT) | YES | |
| RxCUI: 194000 | capecitabine | Full form of descriptor (FN) | YES | |
| RxCUI: 194000 | capecitabine | Designated preferred name (PT) | YES | |
| RxCUI: 194000 | capecitabine | Full form of descriptor (FN) | YES | |
| RxCUI: 1940004 | 1-p-menthene-8-thiol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1940005 | guaraprolose (1300 MPA.S at 1%) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1940006 | isoamyl salicylate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1940006 | isoamyl salicylate | Designated preferred name (PT) | NO | |
| RxCUI: 1940006 | isoamyl salicylate | Full form of descriptor (FN) | NO | |
| RxCUI: 1940007 | methoxy PEG-22/dodecyl glycol copolymer | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1940007 | methoxy PEG-22/dodecyl glycol copolymer | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1940008 | p-anisaldehyde | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1940009 | PEG-10 acrylate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1940010 | PEG-45/dodecyl glycol copolymer | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1940017 | colloidal oatmeal 2 % Medicated Shampoo | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1940017 | colloidal oatmeal 2 % Medicated Shampoo | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1940017 | colloidal oatmeal 2 % Medicated Shampoo | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1940147 | hydrogenated jojoba oil/jojoba oil, randomized (iodine value 64-70) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1940148 | PPG-2 hydroxyethyl isostearamide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1940150 | Dittrichia viscosa whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1940239 | 1 (2 OZ) (salicylic acid 0.5 % Medicated Liquid Soap) / 1 (0.5 OZ) (salicylic acid 0.5 % Topical Cream) Pack | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | NO |
| RxCUI: 1940239 | 1 (2 OZ) (salicylic acid 0.5 % Medicated Liquid Soap) / 1 (0.5 OZ) (salicylic acid 0.5 % Topical Cream) Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1940239 | 1 (2 OZ) (salicylic acid 0.5 % Medicated Liquid Soap) / 1 (0.5 OZ) (salicylic acid 0.5 % Topical Cream) Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1940331 | Enasidenib mesilate | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1940331 | Enasidenib mesilate | Full form of descriptor (FN) | YES | |
| RxCUI: 1940331 | Enasidenib mesilate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1940331 | Enasidenib mesilate | Designated preferred name (PT) | YES | |
| RxCUI: 1940332 | enasidenib | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1940332 | enasidenib | Designated preferred name (PT) | YES | |
| RxCUI: 1940332 | enasidenib | Full form of descriptor (FN) | YES | |
| RxCUI: 1940332 | enasidenib | Designated preferred name (PT) | YES | |
| RxCUI: 1940332 | enasidenib | Full form of descriptor (FN) | YES | |
| RxCUI: 1940334 | enasidenib Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 1940334 | enasidenib Oral Product | Designated preferred name (PT) | YES | |
| RxCUI: 1940334 | enasidenib Oral Product | Full form of descriptor (FN) | YES | |
| RxCUI: 1940335 | enasidenib Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 1940336 | enasidenib Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 1940338 | Idhifa | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 1940340 | enasidenib Oral Tablet [Idhifa] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 1940341 | Idhifa Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1940342 | Idhifa Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1940367 | menthol 5 % / methyl salicylate 10 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1940367 | menthol 5 % / methyl salicylate 10 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1940367 | menthol 5 % / methyl salicylate 10 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1940369 | enasidenib 100 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1940370 | enasidenib 100 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1940370 | enasidenib 100 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1940370 | enasidenib 100 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1940371 | enasidenib 100 MG [Idhifa] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1940372 | IDHIFA 100 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1940372 | IDHIFA 100 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1940372 | IDHIFA 100 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1940373 | enasidenib 50 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1940374 | enasidenib 50 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1940374 | enasidenib 50 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1940374 | enasidenib 50 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1940375 | enasidenib 50 MG [Idhifa] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1940376 | IDHIFA 50 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1940376 | IDHIFA 50 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1940376 | IDHIFA 50 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1940455 | Vanacof AC | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 1940456 | chlophedianol hydrochloride 0.417 MG/ML / pyrilamine maleate 0.833 MG/ML [Vanacof AC] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1940457 | chlophedianol / pyrilamine Oral Solution [Vanacof AC] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 1940458 | Vanacof AC Oral Liquid Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1940459 | Vanacof AC Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1940460 | Vanacof AC 25 MG / 12.5 MG in 30 mL Oral Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1940460 | Vanacof AC 25 MG / 12.5 MG in 30 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1940460 | Vanacof AC 25 MG / 12.5 MG in 30 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1940490 | VetraSeb | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1940491 | chlorhexidine gluconate 20 MG/ML / miconazole nitrate 20 MG/ML / salicyloyl phytosphingosine 0.5 MG/ML [VetraSeb] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1940492 | chlorhexidine / miconazole / salicyloyl phytosphingosine Medicated Shampoo [VetraSeb] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1940493 | VetraSeb Shampoo Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1940494 | VetraSeb M 2 % / 2 % / 0.05 % Medicated Shampoo | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1940494 | VetraSeb M 2 % / 2 % / 0.05 % Medicated Shampoo | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1940494 | VetraSeb M 2 % / 2 % / 0.05 % Medicated Shampoo | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1940495 | dapagliflozin 2.5 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1940496 | dapagliflozin 2.5 MG / metFORMIN HCl 1000 MG 24HR Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1940496 | dapagliflozin 2.5 MG / metFORMIN HCl 1000 MG 24HR Extended Release Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1940496 | dapagliflozin 2.5 MG / metFORMIN HCl 1000 MG 24HR Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1940496 | dapagliflozin 2.5 MG / metFORMIN HCl 1000 MG 24HR Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1940496 | dapagliflozin 2.5 MG / metFORMIN HCl 1000 MG 24HR Extended Release Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1940497 | dapagliflozin 2.5 MG / metFORMIN hydrochloride 1000 MG [Xigduo] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1940497 | dapagliflozin 2.5 MG / metFORMIN hydrochloride 1000 MG [Xigduo] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1940498 | Xigduo XR 2.5/1000 24HR Extended Release Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1940498 | Xigduo XR 2.5/1000 24HR Extended Release Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1940498 | Xigduo XR 2.5/1000 24HR Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1940498 | Xigduo XR 2.5/1000 24HR Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1940499 | dapagliflozin 2.5 MG / metFORMIN hydrochloride 1000 MG Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1940499 | dapagliflozin 2.5 MG / metFORMIN hydrochloride 1000 MG Extended Release Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1940500 | dapagliflozin 2.5 MG / metformin hydrochloride 1000 MG Extended Release Oral Tablet [Xigduo] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1940500 | dapagliflozin 2.5 MG / metformin hydrochloride 1000 MG Extended Release Oral Tablet [Xigduo] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1940626 | Altren | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1940627 | altrenogest 2.2 MG/ML [Altren] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1940628 | altrenogest Oral Solution [Altren] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1940629 | Altren Oral Liquid Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1940630 | Altren Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1940631 | Altren 0.22 % Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1940631 | Altren 0.22 % Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1940631 | Altren 0.22 % Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1940631 | Altren 0.22 % Oral Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1940635 | glecaprevir | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1940635 | glecaprevir | Designated preferred name (PT) | YES | |
| RxCUI: 1940635 | glecaprevir | Full form of descriptor (FN) | YES | |
| RxCUI: 1940635 | glecaprevir | Designated preferred name (PT) | YES | |
| RxCUI: 1940635 | glecaprevir | Full form of descriptor (FN) | YES | |
| RxCUI: 1940636 | pibrentasvir | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1940636 | pibrentasvir | Designated preferred name (PT) | YES | |
| RxCUI: 1940636 | pibrentasvir | Full form of descriptor (FN) | YES | |
| RxCUI: 1940636 | pibrentasvir | Designated preferred name (PT) | YES | |
| RxCUI: 1940636 | pibrentasvir | Full form of descriptor (FN) | YES | |
| RxCUI: 1940642 | neratinib maleate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1940642 | neratinib maleate | Designated preferred name (PT) | YES | |
| RxCUI: 1940642 | neratinib maleate | Full form of descriptor (FN) | YES | |
| RxCUI: 1940643 | neratinib | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1940643 | neratinib | Designated preferred name (PT) | YES | |
| RxCUI: 1940643 | neratinib | Full form of descriptor (FN) | YES | |
| RxCUI: 1940643 | neratinib | Designated preferred name (PT) | YES | |
| RxCUI: 1940643 | neratinib | Full form of descriptor (FN) | YES | |
| RxCUI: 1940644 | neratinib 40 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1940645 | neratinib Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 1940645 | neratinib Oral Product | Designated preferred name (PT) | YES | |
| RxCUI: 1940645 | neratinib Oral Product | Full form of descriptor (FN) | YES | |
| RxCUI: 1940646 | neratinib Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 1940647 | neratinib Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 1940648 | neratinib 40 MG Oral Tablet | Designated preferred name (PT) | YES | |
| RxCUI: 1940648 | neratinib 40 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1940648 | neratinib 40 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1940648 | neratinib 40 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1940648 | neratinib 40 MG Oral Tablet | Full form of descriptor (FN) | YES | |
| RxCUI: 1940649 | Nerlynx | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 1940650 | neratinib 40 MG [Nerlynx] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1940651 | neratinib Oral Tablet [Nerlynx] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 1940652 | Nerlynx Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1940653 | Nerlynx Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1940654 | NERLYNX 40 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1940654 | NERLYNX 40 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1940654 | NERLYNX 40 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1940697 | glecaprevir 100 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1940698 | pibrentasvir 40 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1940699 | glecaprevir / pibrentasvir Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 1940699 | glecaprevir / pibrentasvir Oral Product | Designated preferred name (PT) | YES | |
| RxCUI: 1940699 | glecaprevir / pibrentasvir Oral Product | Full form of descriptor (FN) | YES | |
| RxCUI: 1940700 | glecaprevir / pibrentasvir Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 1940701 | glecaprevir / pibrentasvir Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 1940702 | glecaprevir / pibrentasvir | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | YES |
| RxCUI: 1940702 | glecaprevir / pibrentasvir | Designated preferred name (PT) | YES | |
| RxCUI: 1940702 | glecaprevir / pibrentasvir | Full form of descriptor (FN) | YES | |
| RxCUI: 1940703 | glecaprevir 100 MG / pibrentasvir 40 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1940703 | glecaprevir 100 MG / pibrentasvir 40 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1940703 | glecaprevir 100 MG / pibrentasvir 40 MG Oral Tablet | Designated preferred name (PT) | YES | |
| RxCUI: 1940703 | glecaprevir 100 MG / pibrentasvir 40 MG Oral Tablet | Full form of descriptor (FN) | YES | |
| RxCUI: 1940704 | Mavyret | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 1940705 | glecaprevir 100 MG / pibrentasvir 40 MG [Mavyret] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1940706 | glecaprevir / pibrentasvir Oral Tablet [Mavyret] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 1940707 | Mavyret Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1940708 | Mavyret Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1940709 | Mavyret 100 MG / 40 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1940709 | Mavyret 100 MG / 40 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1940709 | Mavyret 100 MG / 40 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1940778 | Anti-B IgM | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1940778 | Anti-B IgM | Designated preferred name (PT) | NO | |
| RxCUI: 1940778 | Anti-B IgM | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1940778 | Anti-B IgM | Full form of descriptor (FN) | NO | |
| RxCUI: 1940781 | Atypical neutrophil cytoplasmic antibody | Designated preferred name (PT) | NO | |
| RxCUI: 1940781 | Atypical neutrophil cytoplasmic antibody | Full form of descriptor (FN) | NO | |
| RxCUI: 1940782 | Blood group antibody Bx | Designated preferred name (PT) | NO | |
| RxCUI: 1940782 | Blood group antibody Bx | Full form of descriptor (FN) | NO | |
| RxCUI: 1940783 | Blood group antibody Ax | Designated preferred name (PT) | NO | |
| RxCUI: 1940783 | Blood group antibody Ax | Full form of descriptor (FN) | NO | |
| RxCUI: 1940784 | Anti-human leukocyte antigen I type C IgG | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1940784 | Anti-human leukocyte antigen I type C IgG | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1940784 | Anti-human leukocyte antigen I type C IgG | Designated preferred name (PT) | NO | |
| RxCUI: 1940784 | Anti-human leukocyte antigen I type C IgG | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1940784 | Anti-human leukocyte antigen I type C IgG | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1940784 | Anti-human leukocyte antigen I type C IgG | Full form of descriptor (FN) | NO | |
| RxCUI: 1940785 | Anti-B IgG | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1940785 | Anti-B IgG | Designated preferred name (PT) | NO | |
| RxCUI: 1940785 | Anti-B IgG | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1940785 | Anti-B IgG | Full form of descriptor (FN) | NO | |
| RxCUI: 1940786 | Immunoglobulin G antibody to Phlebovirus | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1940786 | Immunoglobulin G antibody to Phlebovirus | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1940786 | Immunoglobulin G antibody to Phlebovirus | Full form of descriptor (FN) | NO | |
| RxCUI: 1940786 | Immunoglobulin G antibody to Phlebovirus | Designated preferred name (PT) | NO | |
| RxCUI: 1940787 | Anti-human leukocyte antigen II type DQ IgG | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1940787 | Anti-human leukocyte antigen II type DQ IgG | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1940787 | Anti-human leukocyte antigen II type DQ IgG | Designated preferred name (PT) | NO | |
| RxCUI: 1940787 | Anti-human leukocyte antigen II type DQ IgG | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1940787 | Anti-human leukocyte antigen II type DQ IgG | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1940787 | Anti-human leukocyte antigen II type DQ IgG | Full form of descriptor (FN) | NO | |
| RxCUI: 1940788 | Anti-human leukocyte antigen I type B IgG | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1940788 | Anti-human leukocyte antigen I type B IgG | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1940788 | Anti-human leukocyte antigen I type B IgG | Designated preferred name (PT) | NO | |
| RxCUI: 1940788 | Anti-human leukocyte antigen I type B IgG | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1940788 | Anti-human leukocyte antigen I type B IgG | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1940788 | Anti-human leukocyte antigen I type B IgG | Full form of descriptor (FN) | NO | |
| RxCUI: 1940790 | Anti-human leukocyte antigen I type A IgG | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1940790 | Anti-human leukocyte antigen I type A IgG | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1940790 | Anti-human leukocyte antigen I type A IgG | Designated preferred name (PT) | NO | |
| RxCUI: 1940790 | Anti-human leukocyte antigen I type A IgG | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1940790 | Anti-human leukocyte antigen I type A IgG | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1940790 | Anti-human leukocyte antigen I type A IgG | Full form of descriptor (FN) | NO | |
| RxCUI: 1940792 | Anti-A IgM | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1940792 | Anti-A IgM | Designated preferred name (PT) | NO | |
| RxCUI: 1940792 | Anti-A IgM | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1940792 | Anti-A IgM | Full form of descriptor (FN) | NO | |
| RxCUI: 1940793 | Anti-human leukocyte antigen II type DP IgG | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1940793 | Anti-human leukocyte antigen II type DP IgG | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1940793 | Anti-human leukocyte antigen II type DP IgG | Designated preferred name (PT) | NO | |
| RxCUI: 1940793 | Anti-human leukocyte antigen II type DP IgG | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1940793 | Anti-human leukocyte antigen II type DP IgG | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1940793 | Anti-human leukocyte antigen II type DP IgG | Full form of descriptor (FN) | NO | |
| RxCUI: 1940794 | Anti-A IgG | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1940794 | Anti-A IgG | Designated preferred name (PT) | NO | |
| RxCUI: 1940794 | Anti-A IgG | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1940794 | Anti-A IgG | Full form of descriptor (FN) | NO | |
| RxCUI: 1940808 | Adult high protein formula | Designated preferred name (PT) | NO | |
| RxCUI: 1940808 | Adult high protein formula | Full form of descriptor (FN) | NO | |
| RxCUI: 1940809 | Adult high protein high fiber formula | Designated preferred name (PT) | NO | |
| RxCUI: 1940809 | Adult high protein high fiber formula | Full form of descriptor (FN) | NO | |
| RxCUI: 1940809 | Adult high protein high fiber formula | British preferred term (PTGB) | NO | |
| RxCUI: 1940810 | Adult hydrolysed protein formula | British preferred term (PTGB) | NO | |
| RxCUI: 1940810 | Adult hydrolysed protein formula | Designated preferred name (PT) | NO | |
| RxCUI: 1940810 | Adult hydrolysed protein formula | Full form of descriptor (FN) | NO | |
| RxCUI: 1940811 | Adult hydrolysed protein metabolic stress critical care specialty formula | British preferred term (PTGB) | NO | |
| RxCUI: 1940811 | Adult hydrolysed protein metabolic stress critical care specialty formula | Designated preferred name (PT) | NO | |
| RxCUI: 1940811 | Adult hydrolysed protein metabolic stress critical care specialty formula | Full form of descriptor (FN) | NO | |
| RxCUI: 1940812 | Adult low carbohydrate formula | Designated preferred name (PT) | NO | |
| RxCUI: 1940812 | Adult low carbohydrate formula | Full form of descriptor (FN) | NO | |
| RxCUI: 1940813 | Diabetic enteral formula with fiber | Designated preferred name (PT) | NO | |
| RxCUI: 1940813 | Diabetic enteral formula with fiber | Full form of descriptor (FN) | NO | |
| RxCUI: 1940813 | Diabetic enteral formula with fiber | British preferred term (PTGB) | NO | |
| RxCUI: 1940814 | Diabetic high calorie high protein enteral formula with fiber | Designated preferred name (PT) | NO | |
| RxCUI: 1940814 | Diabetic high calorie high protein enteral formula with fiber | Full form of descriptor (FN) | NO | |
| RxCUI: 1940814 | Diabetic high calorie high protein enteral formula with fiber | British preferred term (PTGB) | NO | |
| RxCUI: 1940815 | Diabetic specialty enteral formula | Designated preferred name (PT) | NO | |
| RxCUI: 1940815 | Diabetic specialty enteral formula | Full form of descriptor (FN) | NO | |
| RxCUI: 1940819 | Low carbohydrate enteral formula | Designated preferred name (PT) | NO | |
| RxCUI: 1940819 | Low carbohydrate enteral formula | Full form of descriptor (FN) | NO | |
| RxCUI: 1940820 | Hepatic specialty enteral formula | Designated preferred name (PT) | NO | |
| RxCUI: 1940820 | Hepatic specialty enteral formula | Full form of descriptor (FN) | NO | |
| RxCUI: 1940821 | High calorie high protein enteral formula | Designated preferred name (PT) | NO | |
| RxCUI: 1940821 | High calorie high protein enteral formula | Full form of descriptor (FN) | NO | |
| RxCUI: 1940823 | High energy enteral formula with fiber | Designated preferred name (PT) | NO | |
| RxCUI: 1940823 | High energy enteral formula with fiber | Full form of descriptor (FN) | NO | |
| RxCUI: 1940823 | High energy enteral formula with fiber | British preferred term (PTGB) | NO | |
| RxCUI: 1940824 | High calorie formula | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1940824 | High calorie formula | Designated preferred name (PT) | NO | |
| RxCUI: 1940824 | High calorie formula | Full form of descriptor (FN) | NO | |
| RxCUI: 1940825 | High protein formula | Designated preferred name (PT) | NO | |
| RxCUI: 1940825 | High protein formula | Full form of descriptor (FN) | NO | |
| RxCUI: 1940827 | Elemental formula | Designated preferred name (PT) | NO | |
| RxCUI: 1940827 | Elemental formula | Full form of descriptor (FN) | NO | |
| RxCUI: 1940828 | Elemental infant formula | Designated preferred name (PT) | NO | |
| RxCUI: 1940828 | Elemental infant formula | Full form of descriptor (FN) | NO | |
| RxCUI: 1940829 | Hydrolysed peptide-based high protein enteral formula | British preferred term (PTGB) | NO | |
| RxCUI: 1940829 | Hydrolysed peptide-based high protein enteral formula | Designated preferred name (PT) | NO | |
| RxCUI: 1940829 | Hydrolysed peptide-based high protein enteral formula | Full form of descriptor (FN) | NO | |
| RxCUI: 1940830 | Hydrolysed peptide-based protein enteral formula | British preferred term (PTGB) | NO | |
| RxCUI: 1940830 | Hydrolysed peptide-based protein enteral formula | Designated preferred name (PT) | NO | |
| RxCUI: 1940830 | Hydrolysed peptide-based protein enteral formula | Full form of descriptor (FN) | NO | |
| RxCUI: 1940831 | Hydrolysed protein formula | British preferred term (PTGB) | NO | |
| RxCUI: 1940831 | Hydrolysed protein formula | Designated preferred name (PT) | NO | |
| RxCUI: 1940831 | Hydrolysed protein formula | Full form of descriptor (FN) | NO | |
| RxCUI: 1940832 | Hydrolysed protein infant formula | British preferred term (PTGB) | NO | |
| RxCUI: 1940832 | Hydrolysed protein infant formula | Designated preferred name (PT) | NO | |
| RxCUI: 1940832 | Hydrolysed protein infant formula | Full form of descriptor (FN) | NO | |
| RxCUI: 1940833 | Paediatric elemental formula | British preferred term (PTGB) | NO | |
| RxCUI: 1940833 | Paediatric elemental formula | Designated preferred name (PT) | NO | |
| RxCUI: 1940833 | Paediatric elemental formula | Full form of descriptor (FN) | NO | |
| RxCUI: 1940834 | Paediatric formula | British preferred term (PTGB) | NO | |
| RxCUI: 1940834 | Paediatric formula | Designated preferred name (PT) | NO | |
| RxCUI: 1940834 | Paediatric formula | Full form of descriptor (FN) | NO | |
| RxCUI: 1940835 | Pediatric high calorie formula | British synonym (SYGB) | British synonym of another TTY, given for clarity. | NO |
| RxCUI: 1940835 | Pediatric high calorie formula | British preferred term (PTGB) | NO | |
| RxCUI: 1940835 | Pediatric high calorie formula | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1940835 | Pediatric high calorie formula | Designated preferred name (PT) | NO | |
| RxCUI: 1940835 | Pediatric high calorie formula | Full form of descriptor (FN) | NO | |
| RxCUI: 1940836 | Pediatric high calorie formula with increased fiber | British synonym (SYGB) | British synonym of another TTY, given for clarity. | NO |
| RxCUI: 1940836 | Pediatric high calorie formula with increased fiber | British preferred term (PTGB) | NO | |
| RxCUI: 1940836 | Pediatric high calorie formula with increased fiber | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1940836 | Pediatric high calorie formula with increased fiber | Designated preferred name (PT) | NO | |
| RxCUI: 1940836 | Pediatric high calorie formula with increased fiber | Full form of descriptor (FN) | NO | |
| RxCUI: 1940837 | Pediatric high calorie hydrolyzed protein formula | British synonym (SYGB) | British synonym of another TTY, given for clarity. | NO |
| RxCUI: 1940837 | Pediatric high calorie hydrolyzed protein formula | British preferred term (PTGB) | NO | |
| RxCUI: 1940837 | Pediatric high calorie hydrolyzed protein formula | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1940837 | Pediatric high calorie hydrolyzed protein formula | Designated preferred name (PT) | NO | |
| RxCUI: 1940837 | Pediatric high calorie hydrolyzed protein formula | Full form of descriptor (FN) | NO | |
| RxCUI: 1940838 | Paediatric hydrolysed protein formula | British preferred term (PTGB) | NO | |
| RxCUI: 1940838 | Paediatric hydrolysed protein formula | Designated preferred name (PT) | NO | |
| RxCUI: 1940838 | Paediatric hydrolysed protein formula | Full form of descriptor (FN) | NO | |
| RxCUI: 1940839 | Paediatric increased fibre formula | British preferred term (PTGB) | NO | |
| RxCUI: 1940839 | Paediatric increased fibre formula | Designated preferred name (PT) | NO | |
| RxCUI: 1940839 | Paediatric increased fibre formula | Full form of descriptor (FN) | NO | |
| RxCUI: 1940840 | Pediatric reduced calorie formula | British synonym (SYGB) | British synonym of another TTY, given for clarity. | NO |
| RxCUI: 1940840 | Pediatric reduced calorie formula | British preferred term (PTGB) | NO | |
| RxCUI: 1940840 | Pediatric reduced calorie formula | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1940840 | Pediatric reduced calorie formula | Designated preferred name (PT) | NO | |
| RxCUI: 1940840 | Pediatric reduced calorie formula | Full form of descriptor (FN) | NO | |
| RxCUI: 1940841 | Paediatric standard formula | British preferred term (PTGB) | NO | |
| RxCUI: 1940841 | Paediatric standard formula | Designated preferred name (PT) | NO | |
| RxCUI: 1940841 | Paediatric standard formula | Full form of descriptor (FN) | NO | |
| RxCUI: 1940842 | Increased fiber formula | Designated preferred name (PT) | NO | |
| RxCUI: 1940842 | Increased fiber formula | Full form of descriptor (FN) | NO | |
| RxCUI: 1940842 | Increased fiber formula | British preferred term (PTGB) | NO | |
| RxCUI: 1940843 | Critical care specialty enteral formula | Designated preferred name (PT) | NO | |
| RxCUI: 1940843 | Critical care specialty enteral formula | Full form of descriptor (FN) | NO | |
| RxCUI: 1940845 | Soy protein isolate enteral formula | Designated preferred name (PT) | NO | |
| RxCUI: 1940845 | Soy protein isolate enteral formula | Full form of descriptor (FN) | NO | |
| RxCUI: 1940846 | Soy-based formula | Designated preferred name (PT) | NO | |
| RxCUI: 1940846 | Soy-based formula | Full form of descriptor (FN) | NO | |
| RxCUI: 1940848 | Soy-based infant weaning formula | Designated preferred name (PT) | NO | |
| RxCUI: 1940848 | Soy-based infant weaning formula | Full form of descriptor (FN) | NO | |
| RxCUI: 1940849 | Soy-based no added carbohydrate infant formula | Designated preferred name (PT) | NO | |
| RxCUI: 1940849 | Soy-based no added carbohydrate infant formula | Full form of descriptor (FN) | NO | |
| RxCUI: 1940850 | Soy-based standard infant formula | Designated preferred name (PT) | NO | |
| RxCUI: 1940850 | Soy-based standard infant formula | Full form of descriptor (FN) | NO | |
| RxCUI: 1940851 | Standard enteral formula | Designated preferred name (PT) | NO | |
| RxCUI: 1940851 | Standard enteral formula | Full form of descriptor (FN) | NO | |
| RxCUI: 1940852 | Standard enteral formula with fiber | Designated preferred name (PT) | NO | |
| RxCUI: 1940852 | Standard enteral formula with fiber | Full form of descriptor (FN) | NO | |
| RxCUI: 1940852 | Standard enteral formula with fiber | British preferred term (PTGB) | NO | |
| RxCUI: 1940853 | Standard formula | Designated preferred name (PT) | NO | |
| RxCUI: 1940853 | Standard formula | Full form of descriptor (FN) | NO | |
| RxCUI: 1940854 | Standard infant formula | Designated preferred name (PT) | NO | |
| RxCUI: 1940854 | Standard infant formula | Full form of descriptor (FN) | NO | |
| RxCUI: 1940855 | Standard infant formula with fiber | Designated preferred name (PT) | NO | |
| RxCUI: 1940855 | Standard infant formula with fiber | Full form of descriptor (FN) | NO | |
| RxCUI: 1940855 | Standard infant formula with fiber | British preferred term (PTGB) | NO | |
| RxCUI: 1940856 | Standard infant organic formula | Designated preferred name (PT) | NO | |
| RxCUI: 1940856 | Standard infant organic formula | Full form of descriptor (FN) | NO | |
| RxCUI: 1940857 | Standard weaning infant formula | Designated preferred name (PT) | NO | |
| RxCUI: 1940857 | Standard weaning infant formula | Full form of descriptor (FN) | NO | |
| RxCUI: 1940858 | Adult non-dialysis renal specialty formula | Designated preferred name (PT) | NO | |
| RxCUI: 1940858 | Adult non-dialysis renal specialty formula | Full form of descriptor (FN) | NO | |
| RxCUI: 1940859 | Adult pulmonary specialty formula | Designated preferred name (PT) | NO | |
| RxCUI: 1940859 | Adult pulmonary specialty formula | Full form of descriptor (FN) | NO | |
| RxCUI: 1940860 | Adult renal specialty formula | Designated preferred name (PT) | NO | |
| RxCUI: 1940860 | Adult renal specialty formula | Full form of descriptor (FN) | NO | |
| RxCUI: 1940861 | Adult soy protein isolate formula | Designated preferred name (PT) | NO | |
| RxCUI: 1940861 | Adult soy protein isolate formula | Full form of descriptor (FN) | NO | |
| RxCUI: 1940862 | Adult standard formula | Designated preferred name (PT) | NO | |
| RxCUI: 1940862 | Adult standard formula | Full form of descriptor (FN) | NO | |
| RxCUI: 1940863 | Pulmonary specialty enteral formula | Designated preferred name (PT) | NO | |
| RxCUI: 1940863 | Pulmonary specialty enteral formula | Full form of descriptor (FN) | NO | |
| RxCUI: 1940864 | Renal formula | Designated preferred name (PT) | NO | |
| RxCUI: 1940864 | Renal formula | Full form of descriptor (FN) | NO | |
| RxCUI: 1940865 | Renal infant formula | Designated preferred name (PT) | NO | |
| RxCUI: 1940865 | Renal infant formula | Full form of descriptor (FN) | NO | |
| RxCUI: 1940866 | Renal specialty enteral formula | Designated preferred name (PT) | NO | |
| RxCUI: 1940866 | Renal specialty enteral formula | Full form of descriptor (FN) | NO | |
| RxCUI: 1940867 | Adult anti-inflammatory critical care specialty formula | Designated preferred name (PT) | NO | |
| RxCUI: 1940867 | Adult anti-inflammatory critical care specialty formula | Full form of descriptor (FN) | NO | |
| RxCUI: 1940868 | Adult critical care formula | Designated preferred name (PT) | NO | |
| RxCUI: 1940868 | Adult critical care formula | Full form of descriptor (FN) | NO | |
| RxCUI: 1940869 | Adult diabetic specialty formula | Designated preferred name (PT) | NO | |
| RxCUI: 1940869 | Adult diabetic specialty formula | Full form of descriptor (FN) | NO | |
| RxCUI: 1940870 | Adult dialysis renal specialty formula | Designated preferred name (PT) | NO | |
| RxCUI: 1940870 | Adult dialysis renal specialty formula | Full form of descriptor (FN) | NO | |
| RxCUI: 1940871 | Adult dialysis specialty formula | Designated preferred name (PT) | NO | |
| RxCUI: 1940871 | Adult dialysis specialty formula | Full form of descriptor (FN) | NO | |
| RxCUI: 1940872 | Adult elemental GI intolerance critical care specialty formula | Designated preferred name (PT) | NO | |
| RxCUI: 1940872 | Adult elemental GI intolerance critical care specialty formula | Full form of descriptor (FN) | NO | |
| RxCUI: 1940874 | Adult elemental formula | Designated preferred name (PT) | NO | |
| RxCUI: 1940874 | Adult elemental formula | Full form of descriptor (FN) | NO | |
| RxCUI: 1940875 | Adult formula | Designated preferred name (PT) | NO | |
| RxCUI: 1940875 | Adult formula | Full form of descriptor (FN) | NO | |
| RxCUI: 1940876 | Adult hepatic specialty formula | Designated preferred name (PT) | NO | |
| RxCUI: 1940876 | Adult hepatic specialty formula | Full form of descriptor (FN) | NO | |
| RxCUI: 1940877 | Adult high calorie high protein formula | Designated preferred name (PT) | NO | |
| RxCUI: 1940877 | Adult high calorie high protein formula | Full form of descriptor (FN) | NO | |
| RxCUI: 1940878 | Adult high calorie formula | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1940878 | Adult high calorie formula | Designated preferred name (PT) | NO | |
| RxCUI: 1940878 | Adult high calorie formula | Full form of descriptor (FN) | NO | |
| RxCUI: 1940887 | Diabetic meal replacement bar | Designated preferred name (PT) | NO | |
| RxCUI: 1940887 | Diabetic meal replacement bar | Full form of descriptor (FN) | NO | |
| RxCUI: 1940889 | Substance with vesicular monoamine transporter 2 inhibitor mechanism of action | Full form of descriptor (FN) | NO | |
| RxCUI: 1940889 | Substance with vesicular monoamine transporter 2 inhibitor mechanism of action | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1940889 | Substance with vesicular monoamine transporter 2 inhibitor mechanism of action | Full form of descriptor (FN) | NO | |
| RxCUI: 1940889 | Substance with vesicular monoamine transporter 2 inhibitor mechanism of action | Designated preferred name (PT) | NO | |
| RxCUI: 1940889 | Substance with vesicular monoamine transporter 2 inhibitor mechanism of action | Designated preferred name (PT) | NO | |
| RxCUI: 1940889 | Substance with vesicular monoamine transporter 2 inhibitor mechanism of action | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1940896 | Normirtazapine | Designated preferred name (PT) | NO | |
| RxCUI: 1940896 | Normirtazapine | Full form of descriptor (FN) | NO | |
| RxCUI: 1940914 | Magnesium carbonate hydrate | Designated preferred name (PT) | NO | |
| RxCUI: 1940914 | Magnesium carbonate hydrate | Full form of descriptor (FN) | NO | |
| RxCUI: 1940921 | Allo-tetrahydro-11-deoxycortisol | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1940921 | Allo-tetrahydro-11-deoxycortisol | Designated preferred name (PT) | NO | |
| RxCUI: 1940921 | Allo-tetrahydro-11-deoxycortisol | Full form of descriptor (FN) | NO | |
| RxCUI: 1940949 | Methyldrostanolone | Designated preferred name (PT) | NO | |
| RxCUI: 1940949 | Methyldrostanolone | Full form of descriptor (FN) | NO | |
| RxCUI: 1940949 | Methyldrostanolone | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1940956 | Hyoscyamine sulfate dihydrate | Designated preferred name (PT) | NO | |
| RxCUI: 1940956 | Hyoscyamine sulfate dihydrate | Full form of descriptor (FN) | NO | |
| RxCUI: 1940956 | Hyoscyamine sulfate dihydrate | British synonym (SYGB) | British synonym of another TTY, given for clarity. | NO |
| RxCUI: 1940960 | Pemptoporphyrin | Designated preferred name (PT) | NO | |
| RxCUI: 1940960 | Pemptoporphyrin | Full form of descriptor (FN) | NO | |
| RxCUI: 1940965 | APJ endogenous ligand | Designated preferred name (PT) | NO | |
| RxCUI: 1940965 | APJ endogenous ligand | Full form of descriptor (FN) | NO | |
| RxCUI: 1940965 | APJ endogenous ligand | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1940966 | Apomorphine hydrochloride hemihydrate | Designated preferred name (PT) | NO | |
| RxCUI: 1940966 | Apomorphine hydrochloride hemihydrate | Full form of descriptor (FN) | NO | |
| RxCUI: 1940976 | Indapamide hemihydrate | Designated preferred name (PT) | NO | |
| RxCUI: 1940976 | Indapamide hemihydrate | Full form of descriptor (FN) | NO | |
| RxCUI: 194098 | betiatide | Designated preferred name (PT) | YES | |
| RxCUI: 194098 | betiatide | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 194098 | betiatide | Full form of descriptor (FN) | YES | |
| RxCUI: 194098 | betiatide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1940989 | Codeine phosphate hemihydrate | Designated preferred name (PT) | NO | |
| RxCUI: 1940989 | Codeine phosphate hemihydrate | Full form of descriptor (FN) | NO | |
| RxCUI: 1940992 | Irinotecan hydrochloride trihydrate | Designated preferred name (PT) | NO | |
| RxCUI: 1940992 | Irinotecan hydrochloride trihydrate | Full form of descriptor (FN) | NO | |
| RxCUI: 1940993 | Isavuconazonium chloride | Designated preferred name (PT) | NO | |
| RxCUI: 1940993 | Isavuconazonium chloride | Full form of descriptor (FN) | NO | |
| RxCUI: 1941003 | N-Nicotinylglycine | Designated preferred name (PT) | NO | |
| RxCUI: 1941003 | N-Nicotinylglycine | Full form of descriptor (FN) | NO | |
| RxCUI: 1941003 | N-Nicotinylglycine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1941015 | Bromfenac sodium sesquihydrate | Designated preferred name (PT) | NO | |
| RxCUI: 1941015 | Bromfenac sodium sesquihydrate | Full form of descriptor (FN) | NO | |
| RxCUI: 1941030 | Tiagabine hydrochloride monohydrate | Designated preferred name (PT) | NO | |
| RxCUI: 1941030 | Tiagabine hydrochloride monohydrate | Full form of descriptor (FN) | NO | |
| RxCUI: 1941047 | 3-ureidopropionate | Designated preferred name (PT) | NO | |
| RxCUI: 1941047 | 3-ureidopropionate | Full form of descriptor (FN) | NO | |
| RxCUI: 1941049 | Adult clear liquid supplement | Designated preferred name (PT) | NO | |
| RxCUI: 1941049 | Adult clear liquid supplement | Full form of descriptor (FN) | NO | |
| RxCUI: 1941055 | Substance with interleukin-4 receptor alpha antagonist mechanism of action | Designated preferred name (PT) | NO | |
| RxCUI: 1941055 | Substance with interleukin-4 receptor alpha antagonist mechanism of action | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1941055 | Substance with interleukin-4 receptor alpha antagonist mechanism of action | Full form of descriptor (FN) | NO | |
| RxCUI: 1941057 | Substance with tryptophan hydroxylase inhibitor mechanism of action | Full form of descriptor (FN) | NO | |
| RxCUI: 1941057 | Substance with tryptophan hydroxylase inhibitor mechanism of action | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1941057 | Substance with tryptophan hydroxylase inhibitor mechanism of action | Full form of descriptor (FN) | NO | |
| RxCUI: 1941057 | Substance with tryptophan hydroxylase inhibitor mechanism of action | Designated preferred name (PT) | NO | |
| RxCUI: 1941057 | Substance with tryptophan hydroxylase inhibitor mechanism of action | Designated preferred name (PT) | NO | |
| RxCUI: 1941059 | Alkaline phosphatase isoenzyme, intestinal fraction 2 | Designated preferred name (PT) | NO | |
| RxCUI: 1941059 | Alkaline phosphatase isoenzyme, intestinal fraction 2 | Full form of descriptor (FN) | NO | |
| RxCUI: 1941060 | Alkaline phosphatase isoenzyme, intestinal fraction 3 | Designated preferred name (PT) | NO | |
| RxCUI: 1941060 | Alkaline phosphatase isoenzyme, intestinal fraction 3 | Full form of descriptor (FN) | NO | |
| RxCUI: 1941061 | Alkaline phosphatase isoenzyme, placental fraction 2 | Designated preferred name (PT) | NO | |
| RxCUI: 1941061 | Alkaline phosphatase isoenzyme, placental fraction 2 | Full form of descriptor (FN) | NO | |
| RxCUI: 1941062 | Alpha-amylase S4 fraction | Designated preferred name (PT) | NO | |
| RxCUI: 1941062 | Alpha-amylase S4 fraction | Full form of descriptor (FN) | NO | |
| RxCUI: 1941063 | Aluminium hydroxide hydrate | British preferred term (PTGB) | NO | |
| RxCUI: 1941063 | Aluminium hydroxide hydrate | Full form of descriptor (FN) | NO | |
| RxCUI: 1941063 | Aluminium hydroxide hydrate | Designated preferred name (PT) | NO | |
| RxCUI: 1941065 | HLA-B52(5) antigen | Designated preferred name (PT) | NO | |
| RxCUI: 1941065 | HLA-B52(5) antigen | Full form of descriptor (FN) | NO | |
| RxCUI: 1941065 | HLA-B52(5) antigen | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1941069 | Paediatric clear liquid supplement | British preferred term (PTGB) | NO | |
| RxCUI: 1941069 | Paediatric clear liquid supplement | Designated preferred name (PT) | NO | |
| RxCUI: 1941069 | Paediatric clear liquid supplement | Full form of descriptor (FN) | NO | |
| RxCUI: 1941071 | Clear liquid supplement | Designated preferred name (PT) | NO | |
| RxCUI: 1941071 | Clear liquid supplement | Full form of descriptor (FN) | NO | |
| RxCUI: 19411 | Dinucleosidetriphosphatase | Designated preferred name (PT) | NO | |
| RxCUI: 19411 | Dinucleosidetriphosphatase | Full form of descriptor (FN) | NO | |
| RxCUI: 19411 | Dinucleosidetriphosphatase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1941143 | Substance with peroxisome proliferator-activated receptor agonist mechanism of action | Designated preferred name (PT) | NO | |
| RxCUI: 1941143 | Substance with peroxisome proliferator-activated receptor agonist mechanism of action | Designated preferred name (PT) | NO | |
| RxCUI: 1941143 | Substance with peroxisome proliferator-activated receptor agonist mechanism of action | Full form of descriptor (FN) | NO | |
| RxCUI: 1941143 | Substance with peroxisome proliferator-activated receptor agonist mechanism of action | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1941143 | Substance with peroxisome proliferator-activated receptor agonist mechanism of action | Full form of descriptor (FN) | NO | |
| RxCUI: 1941144 | Substance with peroxisome proliferator-activated gamma receptor agonist mechanism of action | Designated preferred name (PT) | NO | |
| RxCUI: 1941144 | Substance with peroxisome proliferator-activated gamma receptor agonist mechanism of action | Designated preferred name (PT) | NO | |
| RxCUI: 1941144 | Substance with peroxisome proliferator-activated gamma receptor agonist mechanism of action | Full form of descriptor (FN) | NO | |
| RxCUI: 1941144 | Substance with peroxisome proliferator-activated gamma receptor agonist mechanism of action | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1941144 | Substance with peroxisome proliferator-activated gamma receptor agonist mechanism of action | Full form of descriptor (FN) | NO | |
| RxCUI: 1941145 | Cobicistat- and elvitegravir- and emtricitabine- and tenofovir-containing product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 1941145 | Cobicistat- and elvitegravir- and emtricitabine- and tenofovir-containing product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 1941146 | Thiamine pyrophosphate tetrahydrate | Designated preferred name (PT) | NO | |
| RxCUI: 1941146 | Thiamine pyrophosphate tetrahydrate | Full form of descriptor (FN) | NO | |
| RxCUI: 1941146 | Thiamine pyrophosphate tetrahydrate | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1941154 | Hb A1 - Hemoglobin A1 | British preferred term (PTGB) | NO | |
| RxCUI: 1941154 | Hb A1 - Hemoglobin A1 | British synonym (SYGB) | British synonym of another TTY, given for clarity. | NO |
| RxCUI: 1941154 | Hb A1 - Hemoglobin A1 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1941154 | Hb A1 - Hemoglobin A1 | Designated preferred name (PT) | NO | |
| RxCUI: 1941154 | Hb A1 - Hemoglobin A1 | Full form of descriptor (FN) | NO | |
| RxCUI: 1941155 | Antibody to pancreatic islet cell 512 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1941155 | Antibody to pancreatic islet cell 512 | Full form of descriptor (FN) | NO | |
| RxCUI: 1941155 | Antibody to pancreatic islet cell 512 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1941155 | Antibody to pancreatic islet cell 512 | Designated preferred name (PT) | NO | |
| RxCUI: 1941155 | Antibody to pancreatic islet cell 512 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1941156 | Substance with guanylate cyclase 2C agonist mechanism of action | Designated preferred name (PT) | NO | |
| RxCUI: 1941156 | Substance with guanylate cyclase 2C agonist mechanism of action | Designated preferred name (PT) | NO | |
| RxCUI: 1941156 | Substance with guanylate cyclase 2C agonist mechanism of action | Full form of descriptor (FN) | NO | |
| RxCUI: 1941156 | Substance with guanylate cyclase 2C agonist mechanism of action | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1941156 | Substance with guanylate cyclase 2C agonist mechanism of action | Full form of descriptor (FN) | NO | |
| RxCUI: 1941157 | Glycyl-tyrosine dihydrate | Designated preferred name (PT) | NO | |
| RxCUI: 1941157 | Glycyl-tyrosine dihydrate | Full form of descriptor (FN) | NO | |
| RxCUI: 1941159 | Free human chorionic gonadotropin beta subunit | Designated preferred name (PT) | NO | |
| RxCUI: 1941159 | Free human chorionic gonadotropin beta subunit | Full form of descriptor (FN) | NO | |
| RxCUI: 1941164 | Substance with smoothened receptor antagonist mechanism of action | Full form of descriptor (FN) | NO | |
| RxCUI: 1941164 | Substance with smoothened receptor antagonist mechanism of action | Designated preferred name (PT) | NO | |
| RxCUI: 1941164 | Substance with smoothened receptor antagonist mechanism of action | Designated preferred name (PT) | NO | |
| RxCUI: 1941164 | Substance with smoothened receptor antagonist mechanism of action | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1941164 | Substance with smoothened receptor antagonist mechanism of action | Full form of descriptor (FN) | NO | |
| RxCUI: 1941166 | Antibody to platelet factor 4-heparin complex | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1941166 | Antibody to platelet factor 4-heparin complex | Full form of descriptor (FN) | NO | |
| RxCUI: 1941166 | Antibody to platelet factor 4-heparin complex | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1941166 | Antibody to platelet factor 4-heparin complex | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1941166 | Antibody to platelet factor 4-heparin complex | Designated preferred name (PT) | NO | |
| RxCUI: 1941166 | Antibody to platelet factor 4-heparin complex | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1941167 | Cerous nitrate hexahydrate | Designated preferred name (PT) | NO | |
| RxCUI: 1941167 | Cerous nitrate hexahydrate | Full form of descriptor (FN) | NO | |
| RxCUI: 1941167 | Cerous nitrate hexahydrate | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1941168 | Antibody to centromere protein B | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1941168 | Antibody to centromere protein B | Full form of descriptor (FN) | NO | |
| RxCUI: 1941168 | Antibody to centromere protein B | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1941168 | Antibody to centromere protein B | Designated preferred name (PT) | NO | |
| RxCUI: 1941168 | Antibody to centromere protein B | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1941169 | Immunoglobulin E antibody to Mangifera indica pollen | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1941169 | Immunoglobulin E antibody to Mangifera indica pollen | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1941169 | Immunoglobulin E antibody to Mangifera indica pollen | Full form of descriptor (FN) | NO | |
| RxCUI: 1941169 | Immunoglobulin E antibody to Mangifera indica pollen | Designated preferred name (PT) | NO | |
| RxCUI: 1941175 | Complement component C4c | Designated preferred name (PT) | NO | |
| RxCUI: 1941175 | Complement component C4c | Full form of descriptor (FN) | NO | |
| RxCUI: 1941180 | Nonacog gamma | Designated preferred name (PT) | NO | |
| RxCUI: 1941180 | Nonacog gamma | Full form of descriptor (FN) | NO | |
| RxCUI: 1941182 | Immunoglobulin E antibody to Rosa species hip | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1941182 | Immunoglobulin E antibody to Rosa species hip | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1941182 | Immunoglobulin E antibody to Rosa species hip | Full form of descriptor (FN) | NO | |
| RxCUI: 1941182 | Immunoglobulin E antibody to Rosa species hip | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1941182 | Immunoglobulin E antibody to Rosa species hip | Designated preferred name (PT) | NO | |
| RxCUI: 1941183 | Reticulocyte component of blood | Designated preferred name (PT) | NO | |
| RxCUI: 1941183 | Reticulocyte component of blood | Full form of descriptor (FN) | NO | |
| RxCUI: 1941184 | L-homoarginine | Designated preferred name (PT) | NO | |
| RxCUI: 1941184 | L-homoarginine | Full form of descriptor (FN) | NO | |
| RxCUI: 1941185 | Crotalidae polyvalent immune FAB equine | Designated preferred name (PT) | NO | |
| RxCUI: 1941185 | Crotalidae polyvalent immune FAB equine | Full form of descriptor (FN) | NO | |
| RxCUI: 19412 | Diadenosinetetraphosphatase (symmetrical) | Designated preferred name (PT) | NO | |
| RxCUI: 19412 | Diadenosinetetraphosphatase (symmetrical) | Full form of descriptor (FN) | NO | |
| RxCUI: 19412 | Diadenosinetetraphosphatase (symmetrical) | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 19412 | Diadenosinetetraphosphatase (symmetrical) | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1941451 | Swinemate | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1941452 | altrenogest 2.2 MG/ML [Swinemate] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1941453 | altrenogest Oral Solution [Swinemate] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1941454 | Swinemate Oral Liquid Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1941455 | Swinemate Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1941456 | SwineMate 0.22 % Oral Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1941456 | SwineMate 0.22 % Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1941456 | SwineMate 0.22 % Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1941456 | SwineMate 0.22 % Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1941461 | chloroxylenol 0.1 % Medicated Liquid Soap | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1941461 | chloroxylenol 0.1 % Medicated Liquid Soap | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1941461 | chloroxylenol 0.1 % Medicated Liquid Soap | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1941462 | linalool oxide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1941463 | nitisinone Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 1941464 | nitisinone 10 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1941464 | nitisinone 10 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1941465 | Nityr | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 1941466 | nitisinone 10 MG [Nityr] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1941467 | nitisinone Oral Tablet [Nityr] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 1941468 | Nityr Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1941469 | Nityr Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1941470 | NITYR 10 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1941470 | NITYR 10 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1941470 | NITYR 10 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1941471 | nitisinone 5 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1941471 | nitisinone 5 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1941472 | nitisinone 5 MG [Nityr] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1941473 | NITYR 5 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1941473 | NITYR 5 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1941473 | NITYR 5 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1941474 | nitisinone 2 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1941474 | nitisinone 2 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1941475 | nitisinone 2 MG [Nityr] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1941476 | NITYR 2 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1941476 | NITYR 2 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1941476 | NITYR 2 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1941484 | Minolira | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 1941485 | minocycline 105 MG [Minolira] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1941486 | minocycline Extended Release Oral Tablet [Minolira] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 1941487 | Minolira Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1941488 | Minolira Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1941489 | minolira 105 MG 24HR Extended Release Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1941489 | minolira 105 MG 24HR Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1941489 | minolira 105 MG 24HR Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1941489 | minolira 105 MG 24HR Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1941489 | minolira 105 MG 24HR Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1941490 | minocycline 105 MG Extended Release Oral Tablet [Minolira] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1941490 | minocycline 105 MG Extended Release Oral Tablet [Minolira] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1941523 | lanolin 15.5 % / petrolatum 30 % Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1941523 | lanolin 15.5 % / petrolatum 30 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1941523 | lanolin 15.5 % / petrolatum 30 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1941523 | lanolin 15.5 % / petrolatum 30 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1941531 | fluticasone propionate 113 MCG/INHAL Dry Powder Inhaler, 60 Actuations | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1941531 | fluticasone propionate 113 MCG/INHAL Dry Powder Inhaler, 60 Actuations | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1941531 | fluticasone propionate 113 MCG/INHAL Dry Powder Inhaler, 60 Actuations | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1941532 | Armonair | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 1941533 | fluticasone propionate 0.113 MG/ACTUAT [Armonair] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1941534 | fluticasone Dry Powder Inhaler [Armonair] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 1941535 | Armonair Inhalant Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1941536 | ArmonAir RespiClick 113 MCG/INHAL Dry Powder Inhaler, 60 Actuations | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1941536 | ArmonAir RespiClick 113 MCG/INHAL Dry Powder Inhaler, 60 Actuations | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1941536 | ArmonAir RespiClick 113 MCG/INHAL Dry Powder Inhaler, 60 Actuations | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1941537 | fluticasone propionate 0.113 MG/ACTUAT Dry Powder Inhaler | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1941538 | fluticasone propionate 0.113 MG/ACTUAT Dry Powder Inhaler [Armonair] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1941538 | fluticasone propionate 0.113 MG/ACTUAT Dry Powder Inhaler [Armonair] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1941587 | synthetic camphor 100 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1941588 | menthol / methyl salicylate / synthetic camphor Topical Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 1941589 | menthol / methyl salicylate / synthetic camphor Topical Spray | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 1941590 | menthol / methyl salicylate / synthetic camphor | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | NO |
| RxCUI: 1941591 | menthol 16 % / methyl salicylate 30 % / synthetic camphor 10 % Topical Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1941591 | menthol 16 % / methyl salicylate 30 % / synthetic camphor 10 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1941591 | menthol 16 % / methyl salicylate 30 % / synthetic camphor 10 % Topical Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1941593 | salicylic acid 18.5 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1941594 | salicylic acid 1.85 % Medicated Shampoo | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1941594 | salicylic acid 1.85 % Medicated Shampoo | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1941595 | Hairsanity | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1941596 | salicylic acid 18.5 MG/ML [Hairsanity] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1941597 | salicylic acid Medicated Shampoo [Hairsanity] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1941598 | Hairsanity Shampoo Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1941599 | HairSanity 1.85 % Medicated Conditioner | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1941599 | HairSanity 1.85 % Medicated Conditioner | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1941599 | HairSanity 1.85 % Medicated Conditioner | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1941599 | HairSanity 1.85 % Medicated Conditioner | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1941599 | HairSanity 1.85 % Medicated Conditioner | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1941605 | fluticasone propionate 232 MCG/INHAL Dry Powder Inhaler, 60 Actuations | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1941605 | fluticasone propionate 232 MCG/INHAL Dry Powder Inhaler, 60 Actuations | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1941605 | fluticasone propionate 232 MCG/INHAL Dry Powder Inhaler, 60 Actuations | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1941606 | fluticasone propionate 0.232 MG/ACTUAT [Armonair] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1941607 | ArmonAir RespiClick 232 MCG/INHAL Dry Powder Inhaler, 60 Actuations | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1941607 | ArmonAir RespiClick 232 MCG/INHAL Dry Powder Inhaler, 60 Actuations | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1941607 | ArmonAir RespiClick 232 MCG/INHAL Dry Powder Inhaler, 60 Actuations | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1941608 | fluticasone propionate 0.232 MG/ACTUAT Dry Powder Inhaler | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1941609 | fluticasone propionate 0.232 MG/ACTUAT Dry Powder Inhaler [Armonair] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1941609 | fluticasone propionate 0.232 MG/ACTUAT Dry Powder Inhaler [Armonair] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1941611 | fluticasone propionate 55 MCG/INHAL Dry Powder Inhaler, 60 Actuations | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1941611 | fluticasone propionate 55 MCG/INHAL Dry Powder Inhaler, 60 Actuations | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1941611 | fluticasone propionate 55 MCG/INHAL Dry Powder Inhaler, 60 Actuations | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1941612 | fluticasone propionate 0.055 MG/ACTUAT [Armonair] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1941613 | ArmonAir RespiClick 55 MCG/INHAL Dry Powder Inhaler, 60 Actuations | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1941613 | ArmonAir RespiClick 55 MCG/INHAL Dry Powder Inhaler, 60 Actuations | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1941613 | ArmonAir RespiClick 55 MCG/INHAL Dry Powder Inhaler, 60 Actuations | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1941614 | fluticasone propionate 0.055 MG/ACTUAT Dry Powder Inhaler | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1941615 | fluticasone propionate 0.055 MG/ACTUAT Dry Powder Inhaler [Armonair] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1941615 | fluticasone propionate 0.055 MG/ACTUAT Dry Powder Inhaler [Armonair] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1941642 | salicylic acid 230 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1941643 | salicylic acid 23 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1941643 | salicylic acid 23 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1941643 | salicylic acid 23 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1941742 | ergocalciferol 62.5 MCG (2500 UNT) Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1941742 | ergocalciferol 62.5 MCG (2500 UNT) Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1941742 | ergocalciferol 62.5 MCG (2500 UNT) Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1941742 | ergocalciferol 62.5 MCG (2500 UNT) Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1941742 | ergocalciferol 62.5 MCG (2500 UNT) Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1941749 | Tenofovir disoproxil phosphate | Designated preferred name (PT) | NO | |
| RxCUI: 1941749 | Tenofovir disoproxil phosphate | Full form of descriptor (FN) | NO | |
| RxCUI: 1941992 | rice bean extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1941993 | triepoxycyclohexasilane | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1942 | Calpain | Designated preferred name (PT) | NO | |
| RxCUI: 1942 | Calpain | Full form of descriptor (FN) | NO | |
| RxCUI: 1942010 | Penicillium chrysogenum var. chrysogenum allergenic extract 200 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1942011 | Penicillium chrysogenum var. chrysogenum extract 0.2 GM/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1942011 | Penicillium chrysogenum var. chrysogenum extract 0.2 GM/ML Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1942011 | Penicillium chrysogenum var. chrysogenum extract 0.2 GM/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1942011 | Penicillium chrysogenum var. chrysogenum extract 0.2 GM/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1942125 | influenza B virus B/Brisbane/46/2015 antigen | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1942126 | influenza B virus B/Brisbane/46/2015 antigen 0.03 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1942127 | influenza virus vaccine 2017-2018 (trivalent generic for Afluria - Hong Kong, Singapore, Brisbane) 0.5 ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1942127 | influenza virus vaccine 2017-2018 (trivalent generic for Afluria - Hong Kong, Singapore, Brisbane) 0.5 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1942127 | influenza virus vaccine 2017-2018 (trivalent generic for Afluria - Hong Kong, Singapore, Brisbane) 0.5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1942128 | Afluria 2017-2018 | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1942129 | influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Singapore/GP1908/2015 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Brisbane/46/2015 antigen 0.03 MG/ML [Afluria 2017-2018] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1942130 | influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Prefilled Syringe [Afluria 2017-2018] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1942131 | Afluria 2017-2018 Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1942132 | Afluria 2017-2018 vaccine 0.5 ML Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1942132 | Afluria 2017-2018 vaccine 0.5 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1942132 | Afluria 2017-2018 vaccine 0.5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1942133 | influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Singapore/GP1908/2015 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Brisbane/46/2015 antigen 0.03 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1942134 | influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Singapore/GP1908/2015 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Brisbane/46/2015 antigen 0.03 MG/ML Prefilled Syringe [Afluria 2017-2018] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1942153 | influenza virus vaccine 2017-2018 (trivalent generic for Afluria - Hong Kong/Singapore/Brisbane) Injectable Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1942153 | influenza virus vaccine 2017-2018 (trivalent generic for Afluria - Hong Kong/Singapore/Brisbane) Injectable Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1942153 | influenza virus vaccine 2017-2018 (trivalent generic for Afluria - Hong Kong/Singapore/Brisbane) Injectable Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1942157 | influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Injectable Suspension [Afluria 2017-2018] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1942158 | Afluria 2017-2018 vaccine Injectable Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1942158 | Afluria 2017-2018 vaccine Injectable Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1942158 | Afluria 2017-2018 vaccine Injectable Suspension | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1942160 | influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen / influenza A virus A/Singapore/GP1908/2015 (H1N1) antigen / influenza B virus B/Brisbane/46/2015 antigen / influenza B virus B/Phuket/3073/2013 antigen | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | NO |
| RxCUI: 1942161 | influenza virus vaccine 2017-2018 (quadrivalent generic for Afluria - Hong Kong/Singapore/Brisbane/Phuket) 0.5 ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1942161 | influenza virus vaccine 2017-2018 (quadrivalent generic for Afluria - Hong Kong/Singapore/Brisbane/Phuket) 0.5 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1942161 | influenza virus vaccine 2017-2018 (quadrivalent generic for Afluria - Hong Kong/Singapore/Brisbane/Phuket) 0.5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1942162 | Afluria Quadrivalent 2017-2018 | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1942163 | influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Singapore/GP1908/2015 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Brisbane/46/2015 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML [Afluria Quadrivalent 2017-2018] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1942164 | influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Prefilled Syringe [Afluria Quadrivalent 2017-2018] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1942165 | Afluria Quadrivalent 2017-2018 Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1942166 | Afluria Quadrivalent 2017-2018 vaccine 0.5 ML Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1942166 | Afluria Quadrivalent 2017-2018 vaccine 0.5 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1942166 | Afluria Quadrivalent 2017-2018 vaccine 0.5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1942167 | influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Singapore/GP1908/2015 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Brisbane/46/2015 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1942168 | influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Singapore/GP1908/2015 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Brisbane/46/2015 antigen 0.03 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 0.03 MG/ML Prefilled Syringe [Afluria Quadrivalent 2017-2018] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1942171 | influenza virus vaccine 2017-2018 (quadrivalent generic for Afluria - Hong Kong/Singapore/Brisbane/Phuket) Injectable Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1942171 | influenza virus vaccine 2017-2018 (quadrivalent generic for Afluria - Hong Kong/Singapore/Brisbane/Phuket) Injectable Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1942171 | influenza virus vaccine 2017-2018 (quadrivalent generic for Afluria - Hong Kong/Singapore/Brisbane/Phuket) Injectable Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1942172 | influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Injectable Suspension [Afluria Quadrivalent 2017-2018] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1942173 | Afluria Quadrivalent 2017-2018 vaccine Injectable Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1942173 | Afluria Quadrivalent 2017-2018 vaccine Injectable Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1942173 | Afluria Quadrivalent 2017-2018 vaccine Injectable Suspension | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1942184 | LolliCaine | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 1942185 | benzocaine 0.2 MG/MG [LolliCaine] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1942186 | benzocaine Oral Gel [LolliCaine] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 1942187 | LolliCaine Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1942188 | LolliCaine Oral Gel Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1942189 | LolliCaine 20 % Oral Gel | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1942189 | LolliCaine 20 % Oral Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1942189 | LolliCaine 20 % Oral Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1942189 | LolliCaine 20 % Oral Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1942263 | sucrose, 6-stearate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1942330 | Hippeastrum puniceum whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1942335 | sodium lauriminodipropionate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1942338 | methyl salicylate 20 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1942338 | methyl salicylate 20 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1942338 | methyl salicylate 20 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1942339 | diphenhydrAMINE / pramoxine Topical Spray | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 1942339 | diphenhydrAMINE / pramoxine Topical Spray | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1942340 | diphenhydrAMINE HCl 1 % / pramoxine HCl 1 % Topical Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1942340 | diphenhydrAMINE HCl 1 % / pramoxine HCl 1 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1942340 | diphenhydrAMINE HCl 1 % / pramoxine HCl 1 % Topical Spray | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1942340 | diphenhydrAMINE HCl 1 % / pramoxine HCl 1 % Topical Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1942340 | diphenhydrAMINE HCl 1 % / pramoxine HCl 1 % Topical Spray | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1942344 | menthol / zinc oxide Rectal Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 1942345 | menthol / zinc oxide Rectal Cream | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 1942346 | menthol 0.45 % / zinc oxide 20 % Rectal Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1942346 | menthol 0.45 % / zinc oxide 20 % Rectal Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1942346 | menthol 0.45 % / zinc oxide 20 % Rectal Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1942346 | menthol 0.45 % / zinc oxide 20 % Rectal Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1942477 | magnesium phosphide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1942478 | triethanolamine hydriodide | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1942479 | umirolimus | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1942480 | olaparib 100 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1942481 | olaparib Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 1942482 | olaparib 100 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1942482 | olaparib 100 MG Oral Tablet | Designated preferred name (PT) | YES | |
| RxCUI: 1942482 | olaparib 100 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1942482 | olaparib 100 MG Oral Tablet | Full form of descriptor (FN) | YES | |
| RxCUI: 1942483 | olaparib 100 MG [Lynparza] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1942484 | olaparib Oral Tablet [Lynparza] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 1942485 | Lynparza 100 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1942485 | Lynparza 100 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1942485 | Lynparza 100 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1942486 | olaparib 150 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1942487 | olaparib 150 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1942487 | olaparib 150 MG Oral Tablet | Designated preferred name (PT) | YES | |
| RxCUI: 1942487 | olaparib 150 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1942487 | olaparib 150 MG Oral Tablet | Full form of descriptor (FN) | YES | |
| RxCUI: 1942488 | olaparib 150 MG [Lynparza] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1942489 | Lynparza 150 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1942489 | Lynparza 150 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1942489 | Lynparza 150 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1942501 | Carprovet | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1942502 | carprofen 100 MG [Carprovet] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1942503 | carprofen Oral Tablet [Carprovet] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1942504 | Carprovet Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1942505 | Carprovet Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1942506 | Carprovet 100 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1942506 | Carprovet 100 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1942506 | Carprovet 100 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1942507 | carprofen 25 MG [Carprovet] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1942508 | Carprovet 25 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1942508 | Carprovet 25 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1942508 | Carprovet 25 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1942510 | carprofen 75 MG [Carprovet] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1942511 | Carprovet 75 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1942511 | Carprovet 75 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1942511 | Carprovet 75 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1942516 | carprofen Oral Tablet [Levafen] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1942517 | Levafen 100 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1942517 | Levafen 100 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1942517 | Levafen 100 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1942518 | Levafen 25 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1942518 | Levafen 25 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1942518 | Levafen 25 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1942519 | Levafen 75 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1942519 | Levafen 75 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1942519 | Levafen 75 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1942520 | imidacloprid 37.5 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1942521 | imidacloprid Chewable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 1942522 | imidacloprid Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 1942523 | imidacloprid Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 1942524 | imidacloprid Chewable Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 1942525 | imidacloprid 37.5 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1942525 | imidacloprid 37.5 MG Chewable Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1942526 | Advantus | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1942527 | imidacloprid 37.5 MG [Advantus] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1942528 | imidacloprid Chewable Tablet [Advantus] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1942529 | Advantus Chewable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1942530 | Advantus Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1942531 | Advantus Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1942532 | Advantus 37.5 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1942532 | Advantus 37.5 MG Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1942532 | Advantus 37.5 MG Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1942532 | Advantus 37.5 MG Chewable Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1942533 | imidacloprid 7.5 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1942534 | imidacloprid 7.5 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1942534 | imidacloprid 7.5 MG Chewable Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1942535 | imidacloprid 7.5 MG [Advantus] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1942536 | Advantus 7.5 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1942536 | Advantus 7.5 MG Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1942536 | Advantus 7.5 MG Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1942536 | Advantus 7.5 MG Chewable Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1942537 | robenacoxib 10 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1942538 | robenacoxib 10 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1942538 | robenacoxib 10 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1942539 | robenacoxib 10 MG [Onsior] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1942540 | Onsior 10 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1942540 | Onsior 10 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1942540 | Onsior 10 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1942696 | Artemisia montana leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1942697 | cocamidopropyl dimethylamine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1942708 | hydroxypropyl bispalmitamide monoethanolamide | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1942709 | hydroxypropyl bispalmitamide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1942710 | hydrogen peroxide 3 % Mouthwash | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1942710 | hydrogen peroxide 3 % Mouthwash | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1942710 | hydrogen peroxide 3 % Mouthwash | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1942738 | cytarabine liposome 100 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1942739 | daunorubicin liposomal 44 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1942739 | daunorubicin liposomal 44 MG | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1942743 | cytarabine 100 MG / DAUNOrubicin 44 MG Liposome Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1942743 | cytarabine 100 MG / DAUNOrubicin 44 MG Liposome Injection | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1942743 | cytarabine 100 MG / DAUNOrubicin 44 MG Liposome Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1942743 | cytarabine 100 MG / DAUNOrubicin 44 MG Liposome Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1942743 | cytarabine 100 MG / DAUNOrubicin 44 MG Liposome Injection | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1942743 | cytarabine 100 MG / DAUNOrubicin 44 MG Liposome Injection | Designated preferred name (PT) | YES | |
| RxCUI: 1942743 | cytarabine 100 MG / DAUNOrubicin 44 MG Liposome Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1942743 | cytarabine 100 MG / DAUNOrubicin 44 MG Liposome Injection | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1942743 | cytarabine 100 MG / DAUNOrubicin 44 MG Liposome Injection | Full form of descriptor (FN) | YES | |
| RxCUI: 1942744 | Vyxeos | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 1942745 | cytarabine liposome 100 MG / daunorubicin liposomal 44 MG [Vyxeos] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1942745 | cytarabine liposome 100 MG / daunorubicin liposomal 44 MG [Vyxeos] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1942747 | Vyxeos Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1942748 | Vyxeos 44 MG / 100 MG Liposome Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1942748 | Vyxeos 44 MG / 100 MG Liposome Injection | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1942748 | Vyxeos 44 MG / 100 MG Liposome Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1942748 | Vyxeos 44 MG / 100 MG Liposome Injection | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1942748 | Vyxeos 44 MG / 100 MG Liposome Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1942748 | Vyxeos 44 MG / 100 MG Liposome Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1942751 | distearoylphosphatidylglycerol, DL- | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1942752 | distearoylphosphatidylglycerol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1942753 | Ala Seb T | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 1942754 | coal tar 10 MG/ML / salicylic acid 20 MG/ML / sulfur 20 MG/ML [Ala Seb T] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1942755 | coal tar / salicylic acid / sulfur Medicated Shampoo [Ala Seb T] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 1942756 | Ala Seb T Shampoo Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1942757 | Ala Seb T 1 % / 2 % / 2 % Medicated Shampoo | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1942757 | Ala Seb T 1 % / 2 % / 2 % Medicated Shampoo | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1942757 | Ala Seb T 1 % / 2 % / 2 % Medicated Shampoo | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 194279 | palivizumab | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 194279 | palivizumab | Designated preferred name (PT) | YES | |
| RxCUI: 194279 | palivizumab | Full form of descriptor (FN) | YES | |
| RxCUI: 194279 | palivizumab | Designated preferred name (PT) | YES | |
| RxCUI: 194279 | palivizumab | Full form of descriptor (FN) | YES | |
| RxCUI: 1942840 | Devrom | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1942841 | bismuth subgallate 200 MG [Devrom] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1942842 | bismuth subgallate Chewable Tablet [Devrom] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1942843 | Devrom Chewable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1942844 | Devrom Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1942845 | Devrom Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1942846 | Devrom 200 MG Chewable Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1942846 | Devrom 200 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1942846 | Devrom 200 MG Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1942847 | salicylic acid 5 % Topical Lotion | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1942847 | salicylic acid 5 % Topical Lotion | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1942847 | salicylic acid 5 % Topical Lotion | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1942878 | lanolin 0.72 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1942879 | lanolin 72 % Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1942879 | lanolin 72 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1942879 | lanolin 72 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1942950 | inotuzumab ozogamicin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1942950 | inotuzumab ozogamicin | Designated preferred name (PT) | YES | |
| RxCUI: 1942950 | inotuzumab ozogamicin | Full form of descriptor (FN) | YES | |
| RxCUI: 1942950 | inotuzumab ozogamicin | Designated preferred name (PT) | YES | |
| RxCUI: 1942950 | inotuzumab ozogamicin | Full form of descriptor (FN) | YES | |
| RxCUI: 1942951 | inotuzumab ozogamicin 0.9 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1942952 | inotuzumab ozogamicin Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 1942952 | inotuzumab ozogamicin Injectable Product | Designated preferred name (PT) | YES | |
| RxCUI: 1942952 | inotuzumab ozogamicin Injectable Product | Full form of descriptor (FN) | YES | |
| RxCUI: 1942953 | inotuzumab ozogamicin Injection | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 1942954 | inotuzumab ozogamicin 0.9 MG Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1942954 | inotuzumab ozogamicin 0.9 MG Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1942955 | Besponsa | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 1942956 | inotuzumab ozogamicin 0.9 MG [Besponsa] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1942957 | inotuzumab ozogamicin Injection [Besponsa] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 1942958 | Besponsa Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1942959 | BESPONSA 0.9 MG Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1942959 | BESPONSA 0.9 MG Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1942959 | BESPONSA 0.9 MG Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1942960 | VIP | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1942960 | VIP | Designated preferred name (PT) | YES | |
| RxCUI: 1942960 | VIP | Full form of descriptor (FN) | YES | |
| RxCUI: 1942960 | VIP | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1942960 | VIP | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1942960 | VIP | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 194315 | Vinflunine | Designated preferred name (PT) | NO | |
| RxCUI: 194315 | Vinflunine | Full form of descriptor (FN) | NO | |
| RxCUI: 1943166 | trideceth-3 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1943187 | Cilazapril monohydrate | Designated preferred name (PT) | NO | |
| RxCUI: 1943187 | Cilazapril monohydrate | Full form of descriptor (FN) | NO | |
| RxCUI: 1943190 | panthenol Shampoo Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 1943191 | panthenol Medicated Shampoo | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 1943192 | panthenol 0.5 % Medicated Shampoo | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1943192 | panthenol 0.5 % Medicated Shampoo | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1943192 | panthenol 0.5 % Medicated Shampoo | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1943336 | zinc oxide 0.4 MG/MG [Aquaphor Diaper Rash] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1943337 | zinc oxide Paste [Aquaphor Diaper Rash] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 1943338 | Aquaphor Diaper Rash Paste Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1943339 | Aquaphor Diaper Rash 40 % Paste | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1943339 | Aquaphor Diaper Rash 40 % Paste | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1943339 | Aquaphor Diaper Rash 40 % Paste | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1943339 | Aquaphor Diaper Rash 40 % Paste | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1943340 | Carospir | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 1943341 | spironolactone 5 MG/ML [Carospir] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1943342 | spironolactone Oral Suspension [Carospir] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 1943343 | Carospir Oral Liquid Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1943344 | Carospir Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1943345 | CaroSpir 25 MG in 5 mL Oral Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1943345 | CaroSpir 25 MG in 5 mL Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1943345 | CaroSpir 25 MG in 5 mL Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1943345 | CaroSpir 25 MG in 5 mL Oral Suspension | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 194337 | Vorinostat | Full form of descriptor (FN) | YES | |
| RxCUI: 194337 | Vorinostat | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 194337 | Vorinostat | Designated preferred name (PT) | YES | |
| RxCUI: 194337 | Vorinostat | Full form of descriptor (FN) | YES | |
| RxCUI: 194337 | Vorinostat | Designated preferred name (PT) | YES | |
| RxCUI: 194342 | Methionine synthase reductase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 194342 | Methionine synthase reductase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 194342 | Methionine synthase reductase | Designated preferred name (PT) | NO | |
| RxCUI: 194342 | Methionine synthase reductase | Full form of descriptor (FN) | NO | |
| RxCUI: 1943485 | hydroxydecyl ubiquinoyl dipalmitoyl glycerate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1943493 | chlophedianol / pseudoephedrine / pyrilamine Oral Liquid Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 1943494 | chlophedianol / pseudoephedrine / pyrilamine Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 1943495 | chlophedianol / pseudoephedrine / pyrilamine Oral Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 1943496 | chlophedianol / pseudoephedrine / pyrilamine | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | YES |
| RxCUI: 1943497 | chlophedianol HCl 12.5 MG / pseudoephedrine HCl 30 MG / pyrilamine maleate 12.5 MG in 5 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1943497 | chlophedianol HCl 12.5 MG / pseudoephedrine HCl 30 MG / pyrilamine maleate 12.5 MG in 5 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1943497 | chlophedianol HCl 12.5 MG / pseudoephedrine HCl 30 MG / pyrilamine maleate 12.5 MG in 5 mL Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1943532 | Rhodiola sacra root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1943536 | benzyl alcohol / lidocaine Topical Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 1943537 | benzyl alcohol 10 % / lidocaine HCl 4 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1943537 | benzyl alcohol 10 % / lidocaine HCl 4 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1943537 | benzyl alcohol 10 % / lidocaine HCl 4 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1943549 | ZoDex 6 Day Taper Package | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | NO |
| RxCUI: 1943549 | ZoDex 6 Day Taper Package | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1943549 | ZoDex 6 Day Taper Package | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1943549 | ZoDex 6 Day Taper Package | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1943550 | dexAMETHasone 1.5 MG Tablet 12 Day 49 Count Pack | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
| RxCUI: 1943550 | dexAMETHasone 1.5 MG Tablet 12 Day 49 Count Pack | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1943550 | dexAMETHasone 1.5 MG Tablet 12 Day 49 Count Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1943550 | dexAMETHasone 1.5 MG Tablet 12 Day 49 Count Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1943550 | dexAMETHasone 1.5 MG Tablet 12 Day 49 Count Pack | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1943551 | Zodex 12 Day Taper Package | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | NO |
| RxCUI: 1943551 | Zodex 12 Day Taper Package | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1943551 | Zodex 12 Day Taper Package | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1943551 | Zodex 12 Day Taper Package | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1943754 | salicylic acid 1 % Topical Solution (50 mL) / salicylic acid 1.5 % Topical Gel (30 mL) / salicylic acid 2 % Medicated Liquid Soap (50 mL) Pack | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | NO |
| RxCUI: 1943754 | salicylic acid 1 % Topical Solution (50 mL) / salicylic acid 1.5 % Topical Gel (30 mL) / salicylic acid 2 % Medicated Liquid Soap (50 mL) Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1943754 | salicylic acid 1 % Topical Solution (50 mL) / salicylic acid 1.5 % Topical Gel (30 mL) / salicylic acid 2 % Medicated Liquid Soap (50 mL) Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1943794 | Enterococcus faecium | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1943799 | glutaric acid | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1943800 | glutarate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1944108 | Arthriten Max | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1944109 | acetaminophen 250 MG / aspirin 250 MG / caffeine 65 MG [Arthriten Max] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1944110 | acetaminophen / aspirin / caffeine Oral Tablet [Arthriten Max] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1944111 | Arthriten Max Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1944112 | Arthriten Max Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1944113 | Arthriten Max 250 MG / 250 MG / 65 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1944113 | Arthriten Max 250 MG / 250 MG / 65 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1944113 | Arthriten Max 250 MG / 250 MG / 65 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1944113 | Arthriten Max 250 MG / 250 MG / 65 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1944248 | almasilate anhydrous | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1944252 | polyethylene oxide 5000000 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1944253 | propylene glycol ricinoleate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1944257 | Flolipid | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 1944258 | simvastatin 4 MG/ML [Flolipid] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1944259 | simvastatin Oral Suspension [Flolipid] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 1944260 | Flolipid Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1944261 | Flolipid Oral Liquid Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1944262 | FloLipid 20 MG in 5 mL Oral Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1944262 | FloLipid 20 MG in 5 mL Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1944262 | FloLipid 20 MG in 5 mL Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1944262 | FloLipid 20 MG in 5 mL Oral Suspension | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1944263 | simvastatin 8 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1944264 | simvastatin 40 MG in 5 mL Oral Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1944264 | simvastatin 40 MG in 5 mL Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1944264 | simvastatin 40 MG in 5 mL Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1944265 | simvastatin 8 MG/ML [Flolipid] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1944266 | FloLipid 40 MG in 5 mL Oral Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1944266 | FloLipid 40 MG in 5 mL Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1944266 | FloLipid 40 MG in 5 mL Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1944266 | FloLipid 40 MG in 5 mL Oral Suspension | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1944368 | amantadine 137 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1944369 | amantadine Extended Release Oral Capsule | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 1944370 | amantadine 137 MG 24HR Extended Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1944370 | amantadine 137 MG 24HR Extended Release Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1944370 | amantadine 137 MG 24HR Extended Release Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1944371 | Gocovri | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 1944372 | amantadine 137 MG [Gocovri] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1944373 | amantadine Extended Release Oral Capsule [Gocovri] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 1944374 | Gocovri Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1944375 | Gocovri Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1944376 | GOCOVRI 137 MG 24HR Extended Release Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1944376 | GOCOVRI 137 MG 24HR Extended Release Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1944376 | GOCOVRI 137 MG 24HR Extended Release Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1944376 | GOCOVRI 137 MG 24HR Extended Release Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1944377 | amantadine 137 MG Extended Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1944378 | amantadine 137 MG Extended Release Oral Capsule [Gocovri] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1944378 | amantadine 137 MG Extended Release Oral Capsule [Gocovri] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1944379 | amantadine 68.5 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1944380 | amantadine 68.5 MG 24HR Extended Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1944380 | amantadine 68.5 MG 24HR Extended Release Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1944380 | amantadine 68.5 MG 24HR Extended Release Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1944381 | amantadine 68.5 MG [Gocovri] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1944382 | GOCOVRI 68.5 MG 24HR Extended Release Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1944382 | GOCOVRI 68.5 MG 24HR Extended Release Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1944382 | GOCOVRI 68.5 MG 24HR Extended Release Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1944382 | GOCOVRI 68.5 MG 24HR Extended Release Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1944383 | amantadine 68.5 MG Extended Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1944384 | amantadine 68.5 MG Extended Release Oral Capsule [Gocovri] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1944384 | amantadine 68.5 MG Extended Release Oral Capsule [Gocovri] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1944385 | Triptodur | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 1944386 | triptorelin 22.5 MG [Triptodur] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1944387 | triptorelin Injection [Triptodur] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 1944388 | Triptodur Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1944389 | Triptodur 22.5 MG Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1944389 | Triptodur 22.5 MG Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1944389 | Triptodur 22.5 MG Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1944524 | ethanol 64 % Topical Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1944524 | ethanol 64 % Topical Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1944524 | ethanol 64 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1944529 | oxyCODONE hydrochloride 15 MG Oral Tablet, Abuse-Deterrent | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1944529 | oxyCODONE hydrochloride 15 MG Oral Tablet, Abuse-Deterrent | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1944529 | oxyCODONE hydrochloride 15 MG Oral Tablet, Abuse-Deterrent | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1944529 | oxyCODONE hydrochloride 15 MG Oral Tablet, Abuse-Deterrent | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1944529 | oxyCODONE hydrochloride 15 MG Oral Tablet, Abuse-Deterrent | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1944530 | Roxybond | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 1944531 | oxycodone hydrochloride 15 MG [Roxybond] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1944531 | oxycodone hydrochloride 15 MG [Roxybond] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1944532 | oxyCODONE Oral Tablet [Roxybond] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 1944532 | oxyCODONE Oral Tablet [Roxybond] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1944533 | Roxybond Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1944534 | Roxybond Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1944535 | RoxyBond 15 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1944535 | RoxyBond 15 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1944535 | RoxyBond 15 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1944535 | RoxyBond 15 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1944538 | oxyCODONE hydrochloride 30 MG Oral Tablet, Abuse-Deterrent | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1944538 | oxyCODONE hydrochloride 30 MG Oral Tablet, Abuse-Deterrent | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1944538 | oxyCODONE hydrochloride 30 MG Oral Tablet, Abuse-Deterrent | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1944538 | oxyCODONE hydrochloride 30 MG Oral Tablet, Abuse-Deterrent | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1944538 | oxyCODONE hydrochloride 30 MG Oral Tablet, Abuse-Deterrent | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1944539 | oxycodone hydrochloride 30 MG [Roxybond] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1944539 | oxycodone hydrochloride 30 MG [Roxybond] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1944540 | RoxyBond 30 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1944540 | RoxyBond 30 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1944540 | RoxyBond 30 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1944540 | RoxyBond 30 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1944541 | oxyCODONE hydrochloride 5 MG Oral Tablet, Abuse-Deterrent | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1944541 | oxyCODONE hydrochloride 5 MG Oral Tablet, Abuse-Deterrent | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1944541 | oxyCODONE hydrochloride 5 MG Oral Tablet, Abuse-Deterrent | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1944541 | oxyCODONE hydrochloride 5 MG Oral Tablet, Abuse-Deterrent | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1944541 | oxyCODONE hydrochloride 5 MG Oral Tablet, Abuse-Deterrent | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1944542 | oxycodone hydrochloride 5 MG [Roxybond] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1944542 | oxycodone hydrochloride 5 MG [Roxybond] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1944543 | RoxyBond 5 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1944543 | RoxyBond 5 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1944543 | RoxyBond 5 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1944543 | RoxyBond 5 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1944548 | camphor 0.8 % / menthol 0.8 % / petrolatum 30 % Topical Stick | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1944548 | camphor 0.8 % / menthol 0.8 % / petrolatum 30 % Topical Stick | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1944548 | camphor 0.8 % / menthol 0.8 % / petrolatum 30 % Topical Stick | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1944626 | trientine hydrochloride 250 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1944628 | trientine hydrochloride 250 MG [Syprine] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1944631 | tocopherol,DL-alpha 100 UNT | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1944633 | thioctic acid 50 MG / tocopherol,DL-alpha 100 UNT / ubidecarenone 30 MG [Q-Gel with Lipoic Acid] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1944636 | ubidecarenone 100 MG / vitamin E 150 UNT [Q-Gel] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1944638 | rabeprazole Granule Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 1944638 | rabeprazole Granule Product | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1944639 | rabeprazole Oral Granules | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 1944639 | rabeprazole Oral Granules | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1944641 | rabeprazole Oral Granules [Aciphex] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 1944641 | rabeprazole Oral Granules [Aciphex] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1944642 | Aciphex Granule Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1944656 | Melodetta 24 Fe Chewable 28 Day Pack | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| RxCUI: 1944656 | Melodetta 24 Fe Chewable 28 Day Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1944656 | Melodetta 24 Fe Chewable 28 Day Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1944687 | sodium pyrophosphate decahydrate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1944692 | miconazole nitrate 2 % Medicated Shampoo | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1944692 | miconazole nitrate 2 % Medicated Shampoo | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1944692 | miconazole nitrate 2 % Medicated Shampoo | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1944699 | gemtuzumab ozogamicin 4.5 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1944700 | gemtuzumab ozogamicin Injection | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 1944701 | gemtuzumab ozogamicin 4.5 MG Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1944701 | gemtuzumab ozogamicin 4.5 MG Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1944702 | gemtuzumab ozogamicin 4.5 MG [Mylotarg] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1944703 | gemtuzumab ozogamicin Injection [Mylotarg] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 1944704 | MYLOTARG 4.5 MG Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1944704 | MYLOTARG 4.5 MG Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1944704 | MYLOTARG 4.5 MG Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1944705 | Carbidopa 25 mg and entacapone 200 mg and levodopa 200 mg oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 1944705 | Carbidopa 25 mg and entacapone 200 mg and levodopa 200 mg oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 1944708 | Potassium aminobenzoate 500 microgram oral capsule | Designated preferred name (PT) | NO | |
| RxCUI: 1944708 | Potassium aminobenzoate 500 microgram oral capsule | Full form of descriptor (FN) | NO | |
| RxCUI: 1944709 | Dexibuprofen 300 mg oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 1944709 | Dexibuprofen 300 mg oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 1944734 | pitavastatin sodium | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1944766 | glycerol (1-(12-hydroxystearate)) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1944770 | Guaifenesin 91.44 mg and theophylline 152.4 mg oral capsule | Designated preferred name (PT) | NO | |
| RxCUI: 1944770 | Guaifenesin 91.44 mg and theophylline 152.4 mg oral capsule | Full form of descriptor (FN) | NO | |
| RxCUI: 1944775 | Allopurinol- and lesinurad-containing product in oral dose form | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 1944775 | Allopurinol- and lesinurad-containing product in oral dose form | Designated preferred name (PT) | YES | |
| RxCUI: 1944775 | Allopurinol- and lesinurad-containing product in oral dose form | Full form of descriptor (FN) | YES | |
| RxCUI: 1944776 | allopurinol / lesinurad Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 1944777 | allopurinol / lesinurad Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 1944778 | Product containing allopurinol and lesinurad (medicinal product) | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | YES |
| RxCUI: 1944778 | Product containing allopurinol and lesinurad (medicinal product) | Designated preferred name (PT) | YES | |
| RxCUI: 1944778 | Product containing allopurinol and lesinurad (medicinal product) | Full form of descriptor (FN) | YES | |
| RxCUI: 1944779 | lesinurad 200 MG / allopurinol 300 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1944779 | lesinurad 200 MG / allopurinol 300 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1944779 | lesinurad 200 MG / allopurinol 300 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1944780 | Duzallo | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 1944781 | allopurinol 300 MG / lesinurad 200 MG [Duzallo] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1944782 | allopurinol / lesinurad Oral Tablet [Duzallo] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 1944783 | Duzallo Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1944784 | Duzallo Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1944785 | DUZALLO 200 MG / 300 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1944785 | DUZALLO 200 MG / 300 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1944785 | DUZALLO 200 MG / 300 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1944786 | lesinurad 200 MG / allopurinol 200 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1944786 | lesinurad 200 MG / allopurinol 200 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1944786 | lesinurad 200 MG / allopurinol 200 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1944787 | allopurinol 200 MG / lesinurad 200 MG [Duzallo] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1944788 | DUZALLO 200 MG / 200 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1944788 | DUZALLO 200 MG / 200 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1944788 | DUZALLO 200 MG / 200 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1944942 | menthol / petrolatum / zinc oxide Paste Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 1944943 | menthol / petrolatum / zinc oxide Paste | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 1944944 | menthol / petrolatum / zinc oxide | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | NO |
| RxCUI: 1944945 | menthol 0.45 % / petrolatum 42 % / zinc oxide 20.6 % Topical Paste | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1944945 | menthol 0.45 % / petrolatum 42 % / zinc oxide 20.6 % Topical Paste | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1944945 | menthol 0.45 % / petrolatum 42 % / zinc oxide 20.6 % Topical Paste | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1944945 | menthol 0.45 % / petrolatum 42 % / zinc oxide 20.6 % Topical Paste | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1944946 | ocriplasmin 1.25 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1944947 | ocriplasmin 0.375 MG in 0.3 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1944947 | ocriplasmin 0.375 MG in 0.3 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1944947 | ocriplasmin 0.375 MG in 0.3 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1944948 | ocriplasmin 1.25 MG/ML [Jetrea] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1944949 | JETREA 0.375 MG in 0.3 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1944949 | JETREA 0.375 MG in 0.3 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1944949 | JETREA 0.375 MG in 0.3 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1944950 | ocriplasmin 1.25 MG/ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1944951 | ocriplasmin 1.25 MG/ML Injection [Jetrea] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1944951 | ocriplasmin 1.25 MG/ML Injection [Jetrea] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1944955 | 3-(l-menthoxy)-2-methylpropane-1,2-diol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1944959 | alpha tocopherol / ascorbic acid / cholecalciferol / doconexent / docusate / ferrous fumarate / folic acid / pyridoxine / tricalcium phosphate Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 1944960 | alpha tocopherol / ascorbic acid / cholecalciferol / doconexent / docusate / ferrous fumarate / folic acid / pyridoxine / tricalcium phosphate Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 1944961 | alpha tocopherol / ascorbic acid / cholecalciferol / doconexent / docusate / ferrous fumarate / folic acid / pyridoxine / tricalcium phosphate Oral Capsule | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 1944962 | alpha tocopherol / ascorbic acid / cholecalciferol / doconexent / docusate / ferrous fumarate / folic acid / pyridoxine / tricalcium phosphate | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | YES |
| RxCUI: 1944988 | Acetylcysteine 100 mg/mL eye drops | Designated preferred name (PT) | NO | |
| RxCUI: 1944988 | Acetylcysteine 100 mg/mL eye drops | Full form of descriptor (FN) | NO | |
| RxCUI: 1945027 | highbush blueberry extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1945036 | fluticasone / umeclidinium / vilanterol Inhalant Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 1945036 | fluticasone / umeclidinium / vilanterol Inhalant Product | Designated preferred name (PT) | YES | |
| RxCUI: 1945036 | fluticasone / umeclidinium / vilanterol Inhalant Product | Full form of descriptor (FN) | YES | |
| RxCUI: 1945037 | fluticasone / umeclidinium / vilanterol Dry Powder Inhaler | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 1945038 | fluticasone / umeclidinium / vilanterol | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | YES |
| RxCUI: 1945038 | fluticasone / umeclidinium / vilanterol | Designated preferred name (PT) | YES | |
| RxCUI: 1945038 | fluticasone / umeclidinium / vilanterol | Full form of descriptor (FN) | YES | |
| RxCUI: 1945039 | fluticasone furoate 100 MCG/ACTUAT / umeclidinium 62.5 MCG/ACTUAT / vilanterol 25 MCG/ACTUAT Dry Powder Inhaler, 14 Blisters | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1945039 | fluticasone furoate 100 MCG/ACTUAT / umeclidinium 62.5 MCG/ACTUAT / vilanterol 25 MCG/ACTUAT Dry Powder Inhaler, 14 Blisters | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1945039 | fluticasone furoate 100 MCG/ACTUAT / umeclidinium 62.5 MCG/ACTUAT / vilanterol 25 MCG/ACTUAT Dry Powder Inhaler, 14 Blisters | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1945040 | Trelegy | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 1945041 | fluticasone furoate 0.1 MG/ACTUAT / umeclidinium 0.0625 MG/ACTUAT / vilanterol 0.025 MG/ACTUAT [Trelegy] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1945042 | fluticasone / umeclidinium / vilanterol Dry Powder Inhaler [Trelegy] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 1945043 | Trelegy Inhalant Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1945044 | TRELEGY ELLIPTA 100 MCG / 62.5 MCG / 25 MCG Dry Powder Inhaler, 14 Blisters | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1945044 | TRELEGY ELLIPTA 100 MCG / 62.5 MCG / 25 MCG Dry Powder Inhaler, 14 Blisters | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1945044 | TRELEGY ELLIPTA 100 MCG / 62.5 MCG / 25 MCG Dry Powder Inhaler, 14 Blisters | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1945045 | fluticasone furoate 0.1 MG/ACTUAT / umeclidinium 0.0625 MG/ACTUAT / vilanterol 0.025 MG/ACTUAT Dry Powder Inhaler | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1945046 | fluticasone furoate 0.1 MG/ACTUAT / umeclidinium 0.0625 MG/ACTUAT / vilanterol 0.025 MG/ACTUAT Dry Powder Inhaler [Trelegy] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1945047 | fluticasone furoate 100 MCG/ACTUAT / umeclidinium 62.5 MCG/ACTUAT / vilanterol 25 MCG/ACTUAT Dry Powder Inhaler, 30 ACTUA | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1945047 | fluticasone furoate 100 MCG/ACTUAT / umeclidinium 62.5 MCG/ACTUAT / vilanterol 25 MCG/ACTUAT Dry Powder Inhaler, 30 ACTUA | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1945047 | fluticasone furoate 100 MCG/ACTUAT / umeclidinium 62.5 MCG/ACTUAT / vilanterol 25 MCG/ACTUAT Dry Powder Inhaler, 30 ACTUA | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1945048 | TRELEGY ELLIPTA 100 MCG / 62.5 MCG / 25 MCG Dry Powder Inhaler, 30 Blisters | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1945048 | TRELEGY ELLIPTA 100 MCG / 62.5 MCG / 25 MCG Dry Powder Inhaler, 30 Blisters | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1945048 | TRELEGY ELLIPTA 100 MCG / 62.5 MCG / 25 MCG Dry Powder Inhaler, 30 Blisters | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1945071 | Decadron DP 1.5 MG Oral Tablet 6 Day 21 Count Pack | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | NO |
| RxCUI: 1945071 | Decadron DP 1.5 MG Oral Tablet 6 Day 21 Count Pack | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1945071 | Decadron DP 1.5 MG Oral Tablet 6 Day 21 Count Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1945071 | Decadron DP 1.5 MG Oral Tablet 6 Day 21 Count Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1945072 | Decadron DP 1.5 MG Oral Tablet 12 Day 49 Count Pack | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | NO |
| RxCUI: 1945072 | Decadron DP 1.5 MG Oral Tablet 12 Day 49 Count Pack | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 1945072 | Decadron DP 1.5 MG Oral Tablet 12 Day 49 Count Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1945072 | Decadron DP 1.5 MG Oral Tablet 12 Day 49 Count Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1945073 | magnesium sulfate 0.4 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1945074 | magnesium sulfate 40 % Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1945074 | magnesium sulfate 40 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1945074 | magnesium sulfate 40 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1945075 | zinc oxide 170 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1945076 | zinc oxide 17 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1945076 | zinc oxide 17 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1945076 | zinc oxide 17 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1945076 | zinc oxide 17 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1945077 | copanlisib | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1945077 | copanlisib | Designated preferred name (PT) | YES | |
| RxCUI: 1945077 | copanlisib | Full form of descriptor (FN) | YES | |
| RxCUI: 1945077 | copanlisib | Designated preferred name (PT) | YES | |
| RxCUI: 1945077 | copanlisib | Full form of descriptor (FN) | YES | |
| RxCUI: 1945078 | copanlisib 60 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1945079 | copanlisib Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 1945079 | copanlisib Injectable Product | Designated preferred name (PT) | YES | |
| RxCUI: 1945079 | copanlisib Injectable Product | Full form of descriptor (FN) | YES | |
| RxCUI: 1945080 | copanlisib Injection | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 1945081 | copanlisib 60 MG Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1945081 | copanlisib 60 MG Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1945082 | Aliqopa | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 1945083 | copanlisib 60 MG [Aliqopa] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1945084 | copanlisib Injection [Aliqopa] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 1945085 | Aliqopa Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1945086 | Aliqopa 60 MG Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1945086 | Aliqopa 60 MG Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1945086 | Aliqopa 60 MG Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1945118 | threonine 200 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1945119 | melatonin / threonine Chewable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 1945120 | melatonin / threonine Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 1945121 | melatonin / threonine Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 1945122 | melatonin / threonine Chewable Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 1945123 | melatonin / threonine | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | YES |
| RxCUI: 1945124 | melatonin 3 MG / threonine 200 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1945124 | melatonin 3 MG / threonine 200 MG Chewable Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1945172 | glycerin 997 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1945173 | glycerin 99.7 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1945173 | glycerin 99.7 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1945173 | glycerin 99.7 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1945174 | glycerin 990 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1945175 | glycerin 99 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1945175 | glycerin 99 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1945175 | glycerin 99 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1945202 | Na-zone | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 1945204 | sodium chloride Nasal Spray [Na-zone] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 1945205 | Na-zone Inhalant Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1945206 | Na-zone Nasal Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1945207 | NA-ZONE 0.65 % Nasal Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1945207 | NA-ZONE 0.65 % Nasal Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1945207 | NA-ZONE 0.65 % Nasal Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1945207 | NA-ZONE 0.65 % Nasal Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1945207 | NA-ZONE 0.65 % Nasal Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1945207 | NA-ZONE 0.65 % Nasal Spray | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1945208 | 5-hydroxytryptophan / melatonin Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 1945209 | 5-hydroxytryptophan / melatonin Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 1945210 | 5-hydroxytryptophan / melatonin Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 1945211 | 5-hydroxytryptophan / melatonin | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | YES |
| RxCUI: 1945212 | melatonin 6 MG / 5-hydroxytryptophan 50 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1945212 | melatonin 6 MG / 5-hydroxytryptophan 50 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1945213 | Vaborbactam | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1945213 | Vaborbactam | Designated preferred name (PT) | YES | |
| RxCUI: 1945213 | Vaborbactam | Full form of descriptor (FN) | YES | |
| RxCUI: 1945214 | vaborbactam 1000 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1945215 | Meropenem- and vaborbactam-containing product in parenteral dose form | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 1945215 | Meropenem- and vaborbactam-containing product in parenteral dose form | Designated preferred name (PT) | YES | |
| RxCUI: 1945215 | Meropenem- and vaborbactam-containing product in parenteral dose form | Full form of descriptor (FN) | YES | |
| RxCUI: 1945216 | meropenem / vaborbactam Injection | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 1945217 | Product containing meropenem and vaborbactam (medicinal product) | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | YES |
| RxCUI: 1945217 | Product containing meropenem and vaborbactam (medicinal product) | Designated preferred name (PT) | YES | |
| RxCUI: 1945217 | Product containing meropenem and vaborbactam (medicinal product) | Full form of descriptor (FN) | YES | |
| RxCUI: 1945218 | meropenem / vaborbactam 2 GM Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1945218 | meropenem / vaborbactam 2 GM Injection | Designated preferred name (PT) | YES | |
| RxCUI: 1945218 | meropenem / vaborbactam 2 GM Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1945218 | meropenem / vaborbactam 2 GM Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1945218 | meropenem / vaborbactam 2 GM Injection | Full form of descriptor (FN) | YES | |
| RxCUI: 1945225 | Phellodendron chinense whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1945226 | American lopseed whole extract | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1945226 | American lopseed whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1945470 | Cayaponia tayuya root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1945471 | Zeltnera venusta whole flowering extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1945475 | acetaminophen 300 MG / butalbital 50 MG / caffeine 40 MG [Phrenilin Forte] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1945476 | acetaminophen / butalbital / caffeine Oral Capsule [Phrenilin Forte] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1945477 | Phrenilin Forte Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1945478 | Phrenilin Forte Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1945479 | Phrenilin Forte 50 MG / 300 MG / 40 MG Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1945479 | Phrenilin Forte 50 MG / 300 MG / 40 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1945479 | Phrenilin Forte 50 MG / 300 MG / 40 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1945479 | Phrenilin Forte 50 MG / 300 MG / 40 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1945481 | Quinine dihydrochloride 300 mg oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 1945481 | Quinine dihydrochloride 300 mg oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 1945481 | Quinine dihydrochloride 300 mg oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 1945481 | Quinine dihydrochloride 300 mg oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 1945838 | Prunus persica flower bud extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1945839 | amphetamine 1.25 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1945840 | amphetamine 1.25 MG/mL Extended Release Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1945840 | amphetamine 1.25 MG/mL Extended Release Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1945841 | amphetamine 1.25 MG/ML [Adzenys] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1945842 | amphetamine Extended Release Suspension [Adzenys] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 1945843 | Adzenys Oral Liquid Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1945844 | Adzenys ER 1.25 MG/ML Extended Release Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1945844 | Adzenys ER 1.25 MG/ML Extended Release Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1945844 | Adzenys ER 1.25 MG/ML Extended Release Suspension | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1945845 | Profeno | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1945846 | fenoprofen 600 MG [Profeno] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1945847 | fenoprofen Oral Tablet [Profeno] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1945848 | Profeno Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1945849 | Profeno Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1945850 | ProFeno 600 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1945850 | ProFeno 600 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1945850 | ProFeno 600 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 19461 | bisabolol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 19461 | bisabolol | Designated preferred name (PT) | YES | |
| RxCUI: 19461 | bisabolol | Full form of descriptor (FN) | YES | |
| RxCUI: 19462 | Bisalbumin | Designated preferred name (PT) | NO | |
| RxCUI: 19462 | Bisalbumin | Full form of descriptor (FN) | NO | |
| RxCUI: 1946395 | Armoracia rusticana whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1946396 | Cinnamomum verum whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1946398 | vigabatrin Oral Powder Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 1946399 | vigabatrin Powder for Oral Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 19464 | bisdequalinium | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1946401 | vigabatrin Powder for Oral Solution [Sabril] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 1946402 | Sabril Oral Powder Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1946471 | lanolin 0.157 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1946472 | petrolatum 0.24 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1946473 | lanolin / menthol / petrolatum / zinc oxide Topical Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 1946474 | lanolin / menthol / petrolatum / zinc oxide Topical Ointment | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 1946475 | lanolin / menthol / petrolatum / zinc oxide | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | YES |
| RxCUI: 1946476 | lanolin 15.7 % / menthol 0.44 % / petrolatum 24 % / zinc oxide 20.6 % Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1946476 | lanolin 15.7 % / menthol 0.44 % / petrolatum 24 % / zinc oxide 20.6 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1946476 | lanolin 15.7 % / menthol 0.44 % / petrolatum 24 % / zinc oxide 20.6 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1946476 | lanolin 15.7 % / menthol 0.44 % / petrolatum 24 % / zinc oxide 20.6 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1946477 | Calmoseptine | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 1946478 | lanolin 0.157 MG/MG / menthol 0.0044 MG/MG / petrolatum 0.24 MG/MG / zinc oxide 0.206 MG/MG [Calmoseptine] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1946479 | lanolin / menthol / petrolatum / zinc oxide Topical Ointment [Calmoseptine] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 1946480 | Calmoseptine Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1946481 | Calmoseptine 15.7 % / 0.44 % / 24 % / 20.6 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1946481 | Calmoseptine 15.7 % / 0.44 % / 24 % / 20.6 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1946481 | Calmoseptine 15.7 % / 0.44 % / 24 % / 20.6 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1946481 | Calmoseptine 15.7 % / 0.44 % / 24 % / 20.6 % Topical Ointment | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1946481 | Calmoseptine 15.7 % / 0.44 % / 24 % / 20.6 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1946519 | leuprolide acetate 30 MG in 1.5 ML (pediatric 3 month) Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1946519 | leuprolide acetate 30 MG in 1.5 ML (pediatric 3 month) Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1946519 | leuprolide acetate 30 MG in 1.5 ML (pediatric 3 month) Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1946519 | leuprolide acetate 30 MG in 1.5 ML (pediatric 3 month) Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1946520 | LUPRON DEPOT-PED 30 MG in 1.5 ML (3 month) Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1946520 | LUPRON DEPOT-PED 30 MG in 1.5 ML (3 month) Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1946520 | LUPRON DEPOT-PED 30 MG in 1.5 ML (3 month) Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1946520 | LUPRON DEPOT-PED 30 MG in 1.5 ML (3 month) Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1946521 | leuprolide acetate 30 MG in 1.5 ML (4 month) Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1946521 | leuprolide acetate 30 MG in 1.5 ML (4 month) Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1946521 | leuprolide acetate 30 MG in 1.5 ML (4 month) Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1946521 | leuprolide acetate 30 MG in 1.5 ML (4 month) Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1946522 | Lupron Depot 30 MG in 1.5 ML (4 month) Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1946522 | Lupron Depot 30 MG in 1.5 ML (4 month) Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1946522 | Lupron Depot 30 MG in 1.5 ML (4 month) Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1946525 | traMADol hydrochloride 300 MG Matrix Delivery 24HR Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1946525 | traMADol hydrochloride 300 MG Matrix Delivery 24HR Extended Release Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1946525 | traMADol hydrochloride 300 MG Matrix Delivery 24HR Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1946525 | traMADol hydrochloride 300 MG Matrix Delivery 24HR Extended Release Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1946525 | traMADol hydrochloride 300 MG Matrix Delivery 24HR Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1946527 | traMADol hydrochloride 200 MG Matrix Delivery 24HR Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1946527 | traMADol hydrochloride 200 MG Matrix Delivery 24HR Extended Release Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1946527 | traMADol hydrochloride 200 MG Matrix Delivery 24HR Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1946527 | traMADol hydrochloride 200 MG Matrix Delivery 24HR Extended Release Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1946527 | traMADol hydrochloride 200 MG Matrix Delivery 24HR Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1946529 | traMADol hydrochloride 100 MG Matrix Delivery 24HR Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1946529 | traMADol hydrochloride 100 MG Matrix Delivery 24HR Extended Release Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1946529 | traMADol hydrochloride 100 MG Matrix Delivery 24HR Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1946529 | traMADol hydrochloride 100 MG Matrix Delivery 24HR Extended Release Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1946529 | traMADol hydrochloride 100 MG Matrix Delivery 24HR Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1946553 | Manihot esculenta whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1946577 | capsaicin 0.03 % / menthol 3 % / methyl salicylate 10 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1946577 | capsaicin 0.03 % / menthol 3 % / methyl salicylate 10 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1946577 | capsaicin 0.03 % / menthol 3 % / methyl salicylate 10 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1946582 | fluticasone propionate 0.093 MG/ACTUAT | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1946583 | fluticasone propionate 93 MCG/ACTUAT Metered Dose Nasal Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1946583 | fluticasone propionate 93 MCG/ACTUAT Metered Dose Nasal Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1946583 | fluticasone propionate 93 MCG/ACTUAT Metered Dose Nasal Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1946584 | Xhance | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 1946585 | fluticasone propionate 0.093 MG/ACTUAT [Xhance] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1946586 | fluticasone Metered Dose Nasal Spray [Xhance] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 1946587 | Xhance Inhalant Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1946588 | Xhance Nasal Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1946589 | XHANCE 93 MCG/ACTUAT Metered Dose Nasal Spray | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1946589 | XHANCE 93 MCG/ACTUAT Metered Dose Nasal Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1946589 | XHANCE 93 MCG/ACTUAT Metered Dose Nasal Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1946589 | XHANCE 93 MCG/ACTUAT Metered Dose Nasal Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1946647 | Vabomere | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 1946648 | meropenem 1000 MG / vaborbactam 1000 MG [Vabomere] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1946649 | meropenem / vaborbactam Injection [Vabomere] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 1946650 | Vabomere Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1946651 | VABOMERE 2 GM Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1946651 | VABOMERE 2 GM Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1946651 | VABOMERE 2 GM Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1946689 | secnidazole 2000 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1946690 | secnidazole Granule Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 1946691 | secnidazole Oral Granules | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 1946692 | secnidazole 2 GM Oral Granules | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1946692 | secnidazole 2 GM Oral Granules | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1946693 | Solosec | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 1946694 | secnidazole 2000 MG [Solosec] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1946695 | secnidazole Oral Granules [Solosec] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 1946696 | Solosec Granule Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1946697 | Solosec Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1946698 | Solosec 2 GM Oral Granules | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1946698 | Solosec 2 GM Oral Granules | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1946698 | Solosec 2 GM Oral Granules | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1946699 | Benson's Bottom Paint | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1946700 | zinc oxide 220 MG/ML [Benson's Bottom Paint] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1946701 | zinc oxide Topical Cream [Benson's Bottom Paint] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1946702 | Benson's Bottom Paint Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1946703 | Benson's Bottom Paint 22 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1946703 | Benson's Bottom Paint 22 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1946703 | Benson's Bottom Paint 22 % Topical Cream | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1946703 | Benson's Bottom Paint 22 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1946723 | Chiggerex | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1946724 | benzocaine 0.1 MG/MG [Chiggerex] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1946725 | benzocaine Topical Ointment [Chiggerex] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1946726 | Chiggerex Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1946727 | Chiggerex 10 % Topical Ointment | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1946727 | Chiggerex 10 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1946727 | Chiggerex 10 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1946730 | chloroprocaine HCl 1 % in 5 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1946730 | chloroprocaine HCl 1 % in 5 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1946730 | chloroprocaine HCl 1 % in 5 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1946731 | Clorotekal | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 1946732 | chloroprocaine hydrochloride 10 MG/ML [Clorotekal] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1946733 | chloroprocaine Injection [Clorotekal] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 1946734 | Clorotekal Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1946735 | Clorotekal 1 % in 5 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1946735 | Clorotekal 1 % in 5 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1946735 | Clorotekal 1 % in 5 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1946736 | chloroprocaine hydrochloride 10 MG/ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1946737 | chloroprocaine hydrochloride 10 MG/ML Injection [Clorotekal] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1946737 | chloroprocaine hydrochloride 10 MG/ML Injection [Clorotekal] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1946772 | methotrexate 25 MG/mL Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1946772 | methotrexate 25 MG/mL Injectable Solution | Designated preferred name (PT) | YES | |
| RxCUI: 1946772 | methotrexate 25 MG/mL Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1946772 | methotrexate 25 MG/mL Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1946772 | methotrexate 25 MG/mL Injectable Solution | Full form of descriptor (FN) | YES | |
| RxCUI: 1946782 | guaiFENesin 388 MG / phenylephrine HCl 10 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1946782 | guaiFENesin 388 MG / phenylephrine HCl 10 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1946782 | guaiFENesin 388 MG / phenylephrine HCl 10 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 1946823 | nonathymulin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1946824 | hypromellose 0.35 % Ophthalmic Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1946824 | hypromellose 0.35 % Ophthalmic Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1946824 | hypromellose 0.35 % Ophthalmic Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1946825 | abemaciclib | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1946825 | abemaciclib | Designated preferred name (PT) | YES | |
| RxCUI: 1946825 | abemaciclib | Full form of descriptor (FN) | YES | |
| RxCUI: 1946825 | abemaciclib | Designated preferred name (PT) | YES | |
| RxCUI: 1946825 | abemaciclib | Full form of descriptor (FN) | YES | |
| RxCUI: 1946826 | abemaciclib 50 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1946827 | abemaciclib Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 1946827 | abemaciclib Oral Product | Designated preferred name (PT) | YES | |
| RxCUI: 1946827 | abemaciclib Oral Product | Full form of descriptor (FN) | YES | |
| RxCUI: 1946828 | abemaciclib Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 1946829 | abemaciclib Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 1946830 | abemaciclib 50 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1946830 | abemaciclib 50 MG Oral Tablet | Designated preferred name (PT) | YES | |
| RxCUI: 1946830 | abemaciclib 50 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1946830 | abemaciclib 50 MG Oral Tablet | Full form of descriptor (FN) | YES | |
| RxCUI: 1946831 | Verzenio | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 1946832 | abemaciclib 50 MG [Verzenio] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1946833 | abemaciclib Oral Tablet [Verzenio] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 1946834 | Verzenio Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1946835 | Verzenio Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1946836 | Verzenio 50 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1946836 | Verzenio 50 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1946836 | Verzenio 50 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1946837 | abemaciclib 100 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1946838 | abemaciclib 100 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1946838 | abemaciclib 100 MG Oral Tablet | Designated preferred name (PT) | YES | |
| RxCUI: 1946838 | abemaciclib 100 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1946838 | abemaciclib 100 MG Oral Tablet | Full form of descriptor (FN) | YES | |
| RxCUI: 1946839 | abemaciclib 100 MG [Verzenio] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1946840 | Verzenio 100 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1946840 | Verzenio 100 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1946840 | Verzenio 100 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1946841 | abemaciclib 150 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1946842 | abemaciclib 150 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1946842 | abemaciclib 150 MG Oral Tablet | Designated preferred name (PT) | YES | |
| RxCUI: 1946842 | abemaciclib 150 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1946842 | abemaciclib 150 MG Oral Tablet | Full form of descriptor (FN) | YES | |
| RxCUI: 1946843 | abemaciclib 150 MG [Verzenio] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1946844 | Verzenio 150 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1946844 | Verzenio 150 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1946844 | Verzenio 150 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1946845 | abemaciclib 200 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1946846 | abemaciclib 200 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1946846 | abemaciclib 200 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1946847 | abemaciclib 200 MG [Verzenio] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1946848 | Verzenio 200 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1946848 | Verzenio 200 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1946848 | Verzenio 200 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 19469 | bismuth carbonate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1946964 | influenza A virus A/Slovenia/2903/2015 (H1N1) antigen | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1946968 | influenza A virus A/New Caledonia/71/2014 (H3N2) antigen / influenza A virus A/Slovenia/2903/2015 (H1N1) antigen / influenza B virus B/Brisbane/60/2008 antigen / influenza B virus B/Phuket/3073/2013 antigen | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | NO |
| RxCUI: 1946970 | Flumist Quadrivalent 2017-2018 | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1946972 | influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Nasal Spray [Flumist Quadrivalent 2017-2018] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1946973 | Flumist Quadrivalent 2017-2018 Inhalant Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1946974 | Flumist Quadrivalent 2017-2018 Nasal Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1946979 | dexbrompheniramine maleate 2 MG / dextromethorphan HBr 20 MG / phenylephrine HCl 10 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1946979 | dexbrompheniramine maleate 2 MG / dextromethorphan HBr 20 MG / phenylephrine HCl 10 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1946980 | influenza A virus A/New Caledonia/71/2014 (H3N2) antigen 158000000 UNT/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1946981 | influenza A virus A/Slovenia/2903/2015 (H1N1) antigen 158000000 UNT/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1946982 | influenza B virus B/Brisbane/60/2008 antigen 158000000 UNT/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1946983 | influenza B virus B/Phuket/3073/2013 antigen 158000000 UNT/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1946984 | influenza virus vaccine 2017-2018 Quadrivalent Nasal Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1946984 | influenza virus vaccine 2017-2018 Quadrivalent Nasal Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1946984 | influenza virus vaccine 2017-2018 Quadrivalent Nasal Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1946985 | influenza A virus A/New Caledonia/71/2014 (H3N2) antigen 158000000 UNT/ML / influenza A virus A/Slovenia/2903/2015 (H1N1) antigen 158000000 UNT/ML / influenza B virus B/Brisbane/60/2008 antigen 158000000 UNT/ML / influenza B virus B/Phuket/3073/2013 antigen 158000000 UNT/ML [Flumist Quadrivalent 2017-2018] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1946986 | FluMist Quadrivalent, 2017-2018 Formula Nasal Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1946986 | FluMist Quadrivalent, 2017-2018 Formula Nasal Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1946986 | FluMist Quadrivalent, 2017-2018 Formula Nasal Spray | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1947 | Calusterone | Designated preferred name (PT) | NO | |
| RxCUI: 1947 | Calusterone | Full form of descriptor (FN) | NO | |
| RxCUI: 1947125 | Zilretta | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 1947127 | triamcinolone Injection [Zilretta] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 1947128 | Zilretta Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1947130 | triamcinolone acetonide 32 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1947131 | triamcinolone acetonide 32 MG Extended-Release Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1947131 | triamcinolone acetonide 32 MG Extended-Release Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1947132 | triamcinolone acetonide 32 MG [Zilretta] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 1947133 | Zilretta 32 MG Extended-Release Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1947133 | Zilretta 32 MG Extended-Release Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1947133 | Zilretta 32 MG Extended-Release Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1947134 | Torphaject | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1947135 | butorphanol 10 MG/ML [Torphaject] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1947136 | butorphanol Injectable Solution [Torphaject] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 1947137 | Torphaject Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 1947138 | TorphaJect 10 MG/ML Injectable Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1947138 | TorphaJect 10 MG/ML Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1947138 | TorphaJect 10 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1947141 | petrolatum 997 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1947142 | petrolatum 99.7 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1947142 | petrolatum 99.7 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1947142 | petrolatum 99.7 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1947144 | poly(DL-lactic-co-glycolic acid) (75:25; 140000 MW) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 1947196 | lidocaine hydrochloride 41.2 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1947197 | lidocaine HCl 4.12 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1947197 | lidocaine HCl 4.12 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1947197 | lidocaine HCl 4.12 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 19472 | bismuth oxide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 19472 | bismuth oxide | Designated preferred name (PT) | NO | |
| RxCUI: 19472 | bismuth oxide | Full form of descriptor (FN) | NO | |
| RxCUI: 194722 | Implanon | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 1947247 | hydroxocobalamin hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1947258 | histamine / menthol / methyl salicylate Topical Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 1947259 | histamine / menthol / methyl salicylate Topical Cream | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 1947260 | histamine / menthol / methyl salicylate | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | NO |
| RxCUI: 1947261 | histamine dihydrochloride 0.050 % / menthol 10 % / methyl salicylate 10 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1947261 | histamine dihydrochloride 0.050 % / menthol 10 % / methyl salicylate 10 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1947261 | histamine dihydrochloride 0.050 % / menthol 10 % / methyl salicylate 10 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1947298 | piridocaine hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1947299 | piridocaine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1947300 | palonosetron 0.125 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 1947301 | palonosetron 0.25 MG in 2 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 1947301 | palonosetron 0.25 MG in 2 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1947301 | palonosetron 0.25 MG in 2 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1947302 | palonosetron 0.125 MG/ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1947367 | menthol 9.4 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 1947368 | menthol 9.4 MG Oral Lozenge | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1947368 | menthol 9.4 MG Oral Lozenge | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 1947369 | menthol 9.4 MG [Halls] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 1947370 | Halls 9.4 MG Oral Lozenge | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 1947370 | Halls 9.4 MG Oral Lozenge | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1947370 | Halls 9.4 MG Oral Lozenge | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 1947371 | sphinganine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1947378 | Fibryga | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 1947381 | Fibryga Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 1947382 | fibryga 1 MG Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 1947382 | fibryga 1 MG Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 1947382 | fibryga 1 MG Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 1947406 | Linum usitatissimum whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1947407 | Bidens pilosa leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1947410 | Coenochloris signiensis extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 19475 | bismuth subcarbonate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 19475 | bismuth subcarbonate | Designated preferred name (PT) | NO | |
| RxCUI: 19475 | bismuth subcarbonate | Full form of descriptor (FN) | NO | |
| RxCUI: 19475 | bismuth subcarbonate | Designated preferred name (PT) | NO | |
| RxCUI: 19475 | bismuth subcarbonate | Full form of descriptor (FN) | NO | |
| RxCUI: 1947500 | propylene glycol propyl ether | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 1947502 | N-(1,3,4-tris(hydroxymethyl)-2,5-dioxo-4-imidazolidinyl)-N,N'-bis(hydroxymethyl)urea | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1947503 | propylene glycol 2-(2-methylbutyrate) | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 1947504 | 2,4,5-T-trolamine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 1947505 | 2-phenylpropanal propylene glycol acetal | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 19476 | bismuth subgallate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 19476 | bismuth subgallate | Designated preferred name (PT) | YES | |
| RxCUI: 19476 | bismuth subgallate | Full form of descriptor (FN) | YES | |
| RxCUI: 19476 | bismuth subgallate | Designated preferred name (PT) | YES | |
| RxCUI: 19476 | bismuth subgallate | Full form of descriptor (FN) | YES | |
| RxCUI: 1947655 | Formocresol | Designated preferred name (PT) | NO | |
| RxCUI: 1947655 | Formocresol | Full form of descriptor (FN) | NO | |
| RxCUI: 1947656 | Human leucocyte antigen Bw55 | Designated preferred name (PT) | NO | |
| RxCUI: 1947656 | Human leucocyte antigen Bw55 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1947656 | Human leucocyte antigen Bw55 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1947656 | Human leucocyte antigen Bw55 | Full form of descriptor (FN) | NO | |
| RxCUI: 19477 | bismuth subnitrate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 19477 | bismuth subnitrate | Designated preferred name (PT) | NO | |
| RxCUI: 19477 | bismuth subnitrate | Full form of descriptor (FN) | NO | |
| RxCUI: 19477 | bismuth subnitrate | Designated preferred name (PT) | NO | |
| RxCUI: 19477 | bismuth subnitrate | Full form of descriptor (FN) | NO | |
| RxCUI: 19478 | bismuth subsalicylate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 19478 | bismuth subsalicylate | Designated preferred name (PT) | YES | |
| RxCUI: 19478 | bismuth subsalicylate | Full form of descriptor (FN) | YES | |
| RxCUI: 19478 | bismuth subsalicylate | Designated preferred name (PT) | YES | |
| RxCUI: 19478 | bismuth subsalicylate | Full form of descriptor (FN) | YES | |
| RxCUI: 19484 | Bisoprolol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 19484 | Bisoprolol | Designated preferred name (PT) | YES | |
| RxCUI: 19484 | Bisoprolol | Full form of descriptor (FN) | YES | |
| RxCUI: 19484 | Bisoprolol | Designated preferred name (PT) | YES | |
| RxCUI: 19484 | Bisoprolol | Full form of descriptor (FN) | YES | |
| RxCUI: 1948455 | Sodium folinate | Designated preferred name (PT) | NO | |
| RxCUI: 1948455 | Sodium folinate | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1948455 | Sodium folinate | Full form of descriptor (FN) | NO | |
| RxCUI: 194881 | brinzolamide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 194881 | brinzolamide | Designated preferred name (PT) | YES | |
| RxCUI: 194881 | brinzolamide | Full form of descriptor (FN) | YES | |
| RxCUI: 194881 | brinzolamide | Designated preferred name (PT) | YES | |
| RxCUI: 194881 | brinzolamide | Full form of descriptor (FN) | YES | |
| RxCUI: 194882 | Azopt | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 19489 | Bisphosphoglycerate phosphatase | Designated preferred name (PT) | NO | |
| RxCUI: 19489 | Bisphosphoglycerate phosphatase | Full form of descriptor (FN) | NO | |
| RxCUI: 1949315 | Antigen of Hepatitis C virus core | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1949315 | Antigen of Hepatitis C virus core | Full form of descriptor (FN) | NO | |
| RxCUI: 1949315 | Antigen of Hepatitis C virus core | Designated preferred name (PT) | NO | |
| RxCUI: 1949315 | Antigen of Hepatitis C virus core | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 1949879 | HbA1c - Glycated hemoglobin-A1c | British preferred term (PTGB) | NO | |
| RxCUI: 1949879 | HbA1c - Glycated hemoglobin-A1c | Designated preferred name (PT) | NO | |
| RxCUI: 1949879 | HbA1c - Glycated hemoglobin-A1c | Full form of descriptor (FN) | NO | |
| RxCUI: 1949879 | HbA1c - Glycated hemoglobin-A1c | British synonym (SYGB) | British synonym of another TTY, given for clarity. | NO |
| RxCUI: 1949879 | HbA1c - Glycated hemoglobin-A1c | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 19499 | bitolterol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 19499 | bitolterol | Designated preferred name (PT) | NO | |
| RxCUI: 19499 | bitolterol | Full form of descriptor (FN) | NO | |
| RxCUI: 19499 | bitolterol | Designated preferred name (PT) | NO | |
| RxCUI: 19499 | bitolterol | Full form of descriptor (FN) | NO |